# Intuit timeline entity: /record/intuit.md id: ent_intuit ## undated - undated | cik | 0000896878 | valid | [clm_0B8EAA54325D](/claim/clm_0B8EAA54325D.md) - undated | state_of_incorporation | DE | valid | [clm_8DEA45AFE5FA](/claim/clm_8DEA45AFE5FA.md) - undated | fiscal_year_end | 07-31 | valid | [clm_A52F46668B97](/claim/clm_A52F46668B97.md) - undated | ticker | INTU | valid | [clm_BD0CCD4ABF34](/claim/clm_BD0CCD4ABF34.md) - undated | sic_industry | Services-Prepackaged Software (7372) | valid | [clm_ED7B8F11C5D1](/claim/clm_ED7B8F11C5D1.md) - undated | member_of | FIDO Alliance | unverified | [clm_2A7F372DA4EB](/claim/clm_2A7F372DA4EB.md) - undated | member_of | Internet Association | unverified | [clm_38E65391D316](/claim/clm_38E65391D316.md) - undated | website | https://www.intuit.com/ | unverified | [clm_6463875C8C9A](/claim/clm_6463875C8C9A.md) - undated | country | United States | valid | [clm_6E2B09452674](/claim/clm_6E2B09452674.md) ## 1983 - 1983-01-01 | founder | Scott Cook | unverified | [clm_97EE5487E3C8](/claim/clm_97EE5487E3C8.md) ## undated - undated | member_of | OpenID Foundation | unverified | [clm_9C8535AA1262](/claim/clm_9C8535AA1262.md) ## 1983 - 1983-01-01 | founder | Thomas Proulx | unverified | [clm_C7111B4BEA4E](/claim/clm_C7111B4BEA4E.md) ## undated - undated | member_of | [Linux Foundation](/record/linux-foundation.md) | unverified | [clm_EB3970AF5B0C](/claim/clm_EB3970AF5B0C.md) - undated | legal_form | Delaware corporation | unverified | [clm_EB527901E832](/claim/clm_EB527901E832.md) ## 1983 - 1983-01-01 | founded | 1983-01-01 | unverified | [clm_FB434014E82A](/claim/clm_FB434014E82A.md) ## 1993 - 1993-01-01 | listed_on | Nasdaq | valid | [clm_1A0DCEEF0255](/claim/clm_1A0DCEEF0255.md) ## 1996 - 1996-10-17 | registrant_name | INTUIT INC. | valid | [clm_3C1A8BF88F31](/claim/clm_3C1A8BF88F31.md) ## 2007 - 2007-03-13 | x_username | Intuit | unverified | [clm_ECC90AF840DF](/claim/clm_ECC90AF840DF.md) - 2007-07-31 to 2008-07-31 | total_equity | 2,036,000,000 United States dollar | superseded | [clm_B94F0AB35809](/claim/clm_B94F0AB35809.md) - 2007-07-31 to 2008-07-31 | cash_and_equivalents | 255,000,000 United States dollar | superseded | [clm_E4BAD90FE762](/claim/clm_E4BAD90FE762.md) - 2007-08-01 to 2008-07-31 | revenue | 2,993,000,000 United States dollar | superseded | [clm_BD947F0FDDFD](/claim/clm_BD947F0FDDFD.md) - 2007-08-01 to 2008-07-31 | net_income | 477,000,000 United States dollar | superseded | [clm_C28C53063E82](/claim/clm_C28C53063E82.md) - 2007-08-01 to 2008-07-31 | operating_income | 644,000,000 United States dollar | superseded | [clm_CBED06C78FF4](/claim/clm_CBED06C78FF4.md) ## 2008 - 2008-07-31 to 2008-08-01 | operating_income | 644,000,000 United States dollar | superseded | [clm_06AE2E679694](/claim/clm_06AE2E679694.md) - 2008-07-31 to 2009-07-31 | research_and_development | 593,000,000 United States dollar | superseded | [clm_770C4CF428BC](/claim/clm_770C4CF428BC.md) - 2008-07-31 to 2008-10-31 | cash_and_equivalents | 413,000,000 United States dollar | superseded | [clm_C620DEEEDD46](/claim/clm_C620DEEEDD46.md) - 2008-07-31 to 2008-08-01 | net_income | 477,000,000 United States dollar | superseded | [clm_D1EE753217BB](/claim/clm_D1EE753217BB.md) - 2008-07-31 to 2008-10-31 | total_equity | 2,080,000,000 United States dollar | superseded | [clm_F8E69620C8DA](/claim/clm_F8E69620C8DA.md) - 2008-07-31 to 2008-08-01 | revenue | 2,993,000,000 United States dollar | superseded | [clm_F95C84DC9582](/claim/clm_F95C84DC9582.md) - 2008-08-01 to 2009-07-31 | net_income | 447,000,000 United States dollar | superseded | [clm_31780F54C923](/claim/clm_31780F54C923.md) - 2008-08-01 to 2009-07-31 | revenue | 3,109,000,000 United States dollar | superseded | [clm_BC8F12F5DDE0](/claim/clm_BC8F12F5DDE0.md) - 2008-08-01 to 2009-07-31 | operating_income | 683,000,000 United States dollar | superseded | [clm_CA61469F3E02](/claim/clm_CA61469F3E02.md) - 2008-10-31 to 2009-01-31 | quarterly_operating_income | -76,000,000 United States dollar | superseded | [clm_02F82BA40742](/claim/clm_02F82BA40742.md) - 2008-10-31 to 2009-01-31 | cash_and_equivalents | 169,000,000 United States dollar | superseded | [clm_25795DB1F002](/claim/clm_25795DB1F002.md) - 2008-10-31 to 2009-01-31 | quarterly_net_income | -52,000,000 United States dollar | superseded | [clm_A4EB56F7756F](/claim/clm_A4EB56F7756F.md) - 2008-10-31 to 2009-01-31 | total_equity | 1,954,000,000 United States dollar | superseded | [clm_B7A3EFFE437F](/claim/clm_B7A3EFFE437F.md) - 2008-10-31 to 2009-01-31 | quarterly_revenue | 481,000,000 United States dollar | superseded | [clm_BF2D4EDB9424](/claim/clm_BF2D4EDB9424.md) - 2008-10-31 to 2009-01-31 | quarterly_research_and_development | 136,000,000 United States dollar | superseded | [clm_CA369C0C139B](/claim/clm_CA369C0C139B.md) ## 2009 - 2009-01-31 to 2009-04-30 | cash_and_equivalents | 339,000,000 United States dollar | superseded | [clm_2C32510477E9](/claim/clm_2C32510477E9.md) - 2009-01-31 to 2009-04-30 | total_equity | 2,036,000,000 United States dollar | superseded | [clm_48A20F7BD453](/claim/clm_48A20F7BD453.md) - 2009-01-31 to 2009-04-30 | quarterly_revenue | 773,000,000 United States dollar | superseded | [clm_7C00F747B820](/claim/clm_7C00F747B820.md) - 2009-01-31 to 2009-04-30 | quarterly_operating_income | 111,000,000 United States dollar | superseded | [clm_9AAAF4F7ADB0](/claim/clm_9AAAF4F7ADB0.md) - 2009-01-31 to 2009-04-30 | quarterly_net_income | 85,000,000 United States dollar | superseded | [clm_C2C556C8670A](/claim/clm_C2C556C8670A.md) - 2009-01-31 to 2009-04-30 | quarterly_research_and_development | 140,000,000 United States dollar | superseded | [clm_C6DCF53E3CC4](/claim/clm_C6DCF53E3CC4.md) - 2009-04-30 to 2009-10-31 | quarterly_operating_income | 765,000,000 United States dollar | superseded | [clm_1F9166AA44C3](/claim/clm_1F9166AA44C3.md) - 2009-04-30 to 2009-07-31 | total_equity | 2,600,000,000 United States dollar | superseded | [clm_54702B2E1847](/claim/clm_54702B2E1847.md) - 2009-04-30 to 2009-07-31 | cash_and_equivalents | 1,222,000,000 United States dollar | superseded | [clm_711F39B17D5F](/claim/clm_711F39B17D5F.md) - 2009-04-30 to 2009-10-31 | quarterly_revenue | 1,417,000,000 United States dollar | superseded | [clm_7BC16860FD53](/claim/clm_7BC16860FD53.md) - 2009-04-30 to 2009-10-31 | quarterly_research_and_development | 130,000,000 United States dollar | superseded | [clm_ACAB2B4F8F19](/claim/clm_ACAB2B4F8F19.md) - 2009-04-30 to 2009-10-31 | quarterly_net_income | 485,000,000 United States dollar | superseded | [clm_B175D2BE3B8E](/claim/clm_B175D2BE3B8E.md) - 2009-07-31 to 2009-10-31 | cash_and_equivalents | 679,000,000 United States dollar | superseded | [clm_3C9D3B455C4D](/claim/clm_3C9D3B455C4D.md) - 2009-07-31 to 2009-08-01 | operating_income | 683,000,000 United States dollar | superseded | [clm_6818B72EDCC3](/claim/clm_6818B72EDCC3.md) - 2009-07-31 to 2009-08-01 | revenue | 3,109,000,000 United States dollar | superseded | [clm_6E427242B939](/claim/clm_6E427242B939.md) - 2009-07-31 to 2010-07-31 | research_and_development | 556,000,000 United States dollar | superseded | [clm_775FBCC82D17](/claim/clm_775FBCC82D17.md) - 2009-07-31 to 2009-08-01 | net_income | 447,000,000 United States dollar | superseded | [clm_82081C7D0446](/claim/clm_82081C7D0446.md) - 2009-07-31 to 2009-10-31 | total_equity | 2,557,000,000 United States dollar | superseded | [clm_D093F9479E5F](/claim/clm_D093F9479E5F.md) - 2009-07-31 to 2009-10-31 | total_assets | 4,826,000,000 United States dollar | superseded | [clm_F9EE31981CB6](/claim/clm_F9EE31981CB6.md) - 2009-08-01 to 2010-07-31 | operating_income | 863,000,000 United States dollar | superseded | [clm_1D3FC99C7C4B](/claim/clm_1D3FC99C7C4B.md) - 2009-08-01 to 2010-07-31 | net_income | 574,000,000 United States dollar | superseded | [clm_6921D8DD5D1D](/claim/clm_6921D8DD5D1D.md) - 2009-08-01 to 2010-07-31 | revenue | 3,455,000,000 United States dollar | superseded | [clm_9D24A44948C4](/claim/clm_9D24A44948C4.md) - 2009-10-31 to 2010-01-31 | quarterly_revenue | 493,000,000 United States dollar | superseded | [clm_1715FD68A4BA](/claim/clm_1715FD68A4BA.md) - 2009-10-31 to 2010-01-31 | total_assets | 4,454,000,000 United States dollar | superseded | [clm_4367051E3518](/claim/clm_4367051E3518.md) - 2009-10-31 to 2010-01-31 | quarterly_operating_income | -99,000,000 United States dollar | superseded | [clm_97199A551486](/claim/clm_97199A551486.md) - 2009-10-31 to 2010-01-31 | total_equity | 2,272,000,000 United States dollar | superseded | [clm_B567B399ECD8](/claim/clm_B567B399ECD8.md) - 2009-10-31 to 2010-01-31 | quarterly_research_and_development | 143,000,000 United States dollar | superseded | [clm_BC0CA1FF3271](/claim/clm_BC0CA1FF3271.md) - 2009-10-31 to 2010-01-31 | quarterly_net_income | -68,000,000 United States dollar | superseded | [clm_EA26A58017FA](/claim/clm_EA26A58017FA.md) - 2009-10-31 to 2010-01-31 | cash_and_equivalents | 313,000,000 United States dollar | superseded | [clm_F11375D62AAA](/claim/clm_F11375D62AAA.md) - 2009-11-23 to 2010-02-22 | shares_outstanding | 316,760,854 shares | superseded | [clm_F450CE8892AF](/claim/clm_F450CE8892AF.md) ## 2010 - 2010-01-31 to 2010-04-30 | total_assets | 4,778,000,000 United States dollar | superseded | [clm_135B49A1459E](/claim/clm_135B49A1459E.md) - 2010-01-31 to 2010-04-30 | cash_and_equivalents | 337,000,000 United States dollar | superseded | [clm_3C0B617306CF](/claim/clm_3C0B617306CF.md) - 2010-01-31 to 2010-04-30 | quarterly_research_and_development | 144,000,000 United States dollar | superseded | [clm_5A66BEBC6E5A](/claim/clm_5A66BEBC6E5A.md) - 2010-01-31 to 2010-04-30 | total_equity | 2,256,000,000 United States dollar | superseded | [clm_A0A10B6AF5A4](/claim/clm_A0A10B6AF5A4.md) - 2010-01-31 to 2010-04-30 | quarterly_revenue | 837,000,000 United States dollar | superseded | [clm_A4C622F440AB](/claim/clm_A4C622F440AB.md) - 2010-01-31 to 2010-04-30 | quarterly_operating_income | 139,000,000 United States dollar | superseded | [clm_D93B7EA1749B](/claim/clm_D93B7EA1749B.md) - 2010-01-31 to 2010-04-30 | quarterly_net_income | 114,000,000 United States dollar | superseded | [clm_E4F7532C8498](/claim/clm_E4F7532C8498.md) - 2010-02-22 to 2010-05-24 | shares_outstanding | 313,918,834 shares | superseded | [clm_D5BD55F49476](/claim/clm_D5BD55F49476.md) - 2010-04-30 to 2010-10-31 | quarterly_net_income | 576,000,000 United States dollar | superseded | [clm_02D45F9B87BF](/claim/clm_02D45F9B87BF.md) - 2010-04-30 to 2010-10-31 | quarterly_revenue | 1,607,000,000 United States dollar | superseded | [clm_468FC9B4309A](/claim/clm_468FC9B4309A.md) - 2010-04-30 to 2010-07-31 | total_equity | 2,858,000,000 United States dollar | superseded | [clm_6B54FC3BD9C1](/claim/clm_6B54FC3BD9C1.md) - 2010-04-30 to 2010-07-31 | cash_and_equivalents | 430,000,000 United States dollar | superseded | [clm_B0D3099DADCA](/claim/clm_B0D3099DADCA.md) - 2010-04-30 to 2010-10-31 | quarterly_research_and_development | 141,000,000 United States dollar | superseded | [clm_B18ED2F66DAE](/claim/clm_B18ED2F66DAE.md) - 2010-04-30 to 2010-07-31 | total_assets | 5,427,000,000 United States dollar | superseded | [clm_CF0E2FBF0082](/claim/clm_CF0E2FBF0082.md) - 2010-04-30 to 2010-10-31 | quarterly_operating_income | 888,000,000 United States dollar | superseded | [clm_EB3C24B50867](/claim/clm_EB3C24B50867.md) - 2010-05-24 to 2010-08-31 | shares_outstanding | 314,117,010 shares | superseded | [clm_8302CF596AB3](/claim/clm_8302CF596AB3.md) - 2010-07-31 to 2010-10-31 | total_equity | 2,821,000,000 United States dollar | superseded | [clm_1D1DFF777B3F](/claim/clm_1D1DFF777B3F.md) - 2010-07-31 to 2010-08-01 | revenue | 3,455,000,000 United States dollar | superseded | [clm_458DD5D69C62](/claim/clm_458DD5D69C62.md) - 2010-07-31 to 2010-10-31 | cash_and_equivalents | 214,000,000 United States dollar | superseded | [clm_4B5C02F06111](/claim/clm_4B5C02F06111.md) - 2010-07-31 to 2010-08-01 | operating_income | 863,000,000 United States dollar | superseded | [clm_523BC6861E62](/claim/clm_523BC6861E62.md) - 2010-07-31 to 2011-07-31 | research_and_development | 573,000,000 United States dollar | superseded | [clm_EC313B8970E3](/claim/clm_EC313B8970E3.md) - 2010-07-31 to 2010-08-01 | net_income | 574,000,000 United States dollar | superseded | [clm_EE31CC4D8169](/claim/clm_EE31CC4D8169.md) - 2010-07-31 to 2010-10-31 | total_assets | 5,198,000,000 United States dollar | superseded | [clm_F164BEDB3704](/claim/clm_F164BEDB3704.md) - 2010-08-01 to 2011-07-31 | operating_income | 1,007,000,000 United States dollar | superseded | [clm_28A5D5F02372](/claim/clm_28A5D5F02372.md) - 2010-08-01 to 2011-07-31 | net_income | 634,000,000 United States dollar | superseded | [clm_AEC7B2647F49](/claim/clm_AEC7B2647F49.md) - 2010-08-01 to 2011-07-31 | revenue | 3,851,000,000 United States dollar | superseded | [clm_BED912E05BE3](/claim/clm_BED912E05BE3.md) - 2010-08-31 to 2010-11-30 | shares_outstanding | 317,535,557 shares | superseded | [clm_8D4AC29ACDDF](/claim/clm_8D4AC29ACDDF.md) - 2010-10-31 to 2011-01-31 | quarterly_net_income | -70,000,000 United States dollar | superseded | [clm_4972A2BFB7FF](/claim/clm_4972A2BFB7FF.md) - 2010-10-31 to 2011-01-31 | quarterly_revenue | 532,000,000 United States dollar | superseded | [clm_935B0C38FBCD](/claim/clm_935B0C38FBCD.md) - 2010-10-31 to 2011-01-31 | total_equity | 2,615,000,000 United States dollar | superseded | [clm_9A600AC23605](/claim/clm_9A600AC23605.md) - 2010-10-31 to 2011-01-31 | total_assets | 4,943,000,000 United States dollar | superseded | [clm_AADA18B38675](/claim/clm_AADA18B38675.md) - 2010-10-31 to 2011-01-31 | quarterly_operating_income | -104,000,000 United States dollar | superseded | [clm_BC45644A71DA](/claim/clm_BC45644A71DA.md) - 2010-10-31 to 2011-01-31 | quarterly_research_and_development | 156,000,000 United States dollar | superseded | [clm_C9435203CA21](/claim/clm_C9435203CA21.md) - 2010-10-31 to 2011-01-31 | cash_and_equivalents | 112,000,000 United States dollar | superseded | [clm_DE31BCD77719](/claim/clm_DE31BCD77719.md) - 2010-11-30 to 2011-02-22 | shares_outstanding | 310,610,837 shares | superseded | [clm_9415D9CC0935](/claim/clm_9415D9CC0935.md) ## 2011 - 2011-01-31 to 2011-04-30 | cash_and_equivalents | 433,000,000 United States dollar | superseded | [clm_039BE778E1C3](/claim/clm_039BE778E1C3.md) - 2011-01-31 to 2011-04-30 | quarterly_net_income | 73,000,000 United States dollar | superseded | [clm_40ACB2A4E4C4](/claim/clm_40ACB2A4E4C4.md) - 2011-01-31 to 2011-04-30 | total_equity | 2,272,000,000 United States dollar | superseded | [clm_4DAA30CFE05D](/claim/clm_4DAA30CFE05D.md) - 2011-01-31 to 2011-04-30 | quarterly_revenue | 878,000,000 United States dollar | superseded | [clm_70D57350F20F](/claim/clm_70D57350F20F.md) - 2011-01-31 to 2011-04-30 | quarterly_research_and_development | 158,000,000 United States dollar | superseded | [clm_EE6B1F662493](/claim/clm_EE6B1F662493.md) - 2011-01-31 to 2011-04-30 | total_assets | 4,979,000,000 United States dollar | superseded | [clm_FB6CE611AD9D](/claim/clm_FB6CE611AD9D.md) - 2011-02-22 to 2011-05-23 | shares_outstanding | 302,580,717 shares | superseded | [clm_F11972D829DA](/claim/clm_F11972D829DA.md) - 2011-04-30 to 2011-07-31 | total_equity | 2,821,000,000 United States dollar | superseded | [clm_64ABDFDD3AF3](/claim/clm_64ABDFDD3AF3.md) - 2011-04-30 to 2011-10-31 | quarterly_operating_income | 1,061,000,000 United States dollar | superseded | [clm_8729FC47498E](/claim/clm_8729FC47498E.md) - 2011-04-30 to 2011-10-31 | quarterly_net_income | 688,000,000 United States dollar | superseded | [clm_942EFB16E128](/claim/clm_942EFB16E128.md) - 2011-04-30 to 2011-10-31 | quarterly_revenue | 1,848,000,000 United States dollar | superseded | [clm_C64EF0FDF16A](/claim/clm_C64EF0FDF16A.md) - 2011-04-30 to 2011-07-31 | cash_and_equivalents | 1,369,000,000 United States dollar | superseded | [clm_CD03E46488DE](/claim/clm_CD03E46488DE.md) - 2011-04-30 to 2011-10-31 | quarterly_research_and_development | 164,000,000 United States dollar | superseded | [clm_D63BBEFC19DA](/claim/clm_D63BBEFC19DA.md) - 2011-04-30 to 2011-07-31 | total_assets | 5,567,000,000 United States dollar | superseded | [clm_EF71AB71658F](/claim/clm_EF71AB71658F.md) - 2011-05-23 to 2011-08-31 | shares_outstanding | 304,000,417 shares | superseded | [clm_E370EDBC6489](/claim/clm_E370EDBC6489.md) - 2011-07-31 to 2011-08-01 | net_income | 634,000,000 United States dollar | superseded | [clm_034A5EABE98E](/claim/clm_034A5EABE98E.md) - 2011-07-31 to 2011-10-31 | cash_and_equivalents | 722,000,000 United States dollar | superseded | [clm_629DACE637F9](/claim/clm_629DACE637F9.md) - 2011-07-31 to 2011-08-01 | revenue | 3,851,000,000 United States dollar | superseded | [clm_64047D33A987](/claim/clm_64047D33A987.md) - 2011-07-31 to 2011-08-01 | operating_income | 1,007,000,000 United States dollar | superseded | [clm_84B936F34AB5](/claim/clm_84B936F34AB5.md) - 2011-07-31 to 2011-10-31 | total_assets | 5,110,000,000 United States dollar | superseded | [clm_A7FFCD81A4BE](/claim/clm_A7FFCD81A4BE.md) - 2011-07-31 to 2011-10-31 | total_equity | 2,616,000,000 United States dollar | superseded | [clm_B83796FCBD56](/claim/clm_B83796FCBD56.md) - 2011-07-31 to 2012-07-31 | research_and_development | 634,000,000 United States dollar | superseded | [clm_BCB11531A3CE](/claim/clm_BCB11531A3CE.md) - 2011-08-01 to 2012-07-31 | net_income | 792,000,000 United States dollar | superseded | [clm_6588DD713E98](/claim/clm_6588DD713E98.md) - 2011-08-01 to 2012-07-31 | operating_income | 1,177,000,000 United States dollar | superseded | [clm_65F1562DFB8A](/claim/clm_65F1562DFB8A.md) - 2011-08-01 to 2012-07-31 | revenue | 4,151,000,000 United States dollar | superseded | [clm_AFFDC87A694A](/claim/clm_AFFDC87A694A.md) - 2011-08-31 to 2011-11-23 | shares_outstanding | 300,814,069 shares | superseded | [clm_EF3619C5B4C8](/claim/clm_EF3619C5B4C8.md) - 2011-10-31 to 2012-01-31 | total_assets | 4,683,000,000 United States dollar | superseded | [clm_2CBFCD5D630E](/claim/clm_2CBFCD5D630E.md) - 2011-10-31 to 2012-01-31 | quarterly_research_and_development | 167,000,000 United States dollar | superseded | [clm_73F9376858A1](/claim/clm_73F9376858A1.md) - 2011-10-31 to 2012-01-31 | quarterly_net_income | -64,000,000 United States dollar | superseded | [clm_9F5262C34230](/claim/clm_9F5262C34230.md) - 2011-10-31 to 2012-01-31 | quarterly_revenue | 594,000,000 United States dollar | superseded | [clm_A1C2BDADAF37](/claim/clm_A1C2BDADAF37.md) - 2011-10-31 to 2012-01-31 | cash_and_equivalents | 333,000,000 United States dollar | superseded | [clm_C928D1160F2B](/claim/clm_C928D1160F2B.md) - 2011-10-31 to 2012-01-31 | quarterly_operating_income | -94,000,000 United States dollar | superseded | [clm_D528E7A7246F](/claim/clm_D528E7A7246F.md) - 2011-10-31 to 2012-01-31 | total_equity | 2,361,000,000 United States dollar | superseded | [clm_E0A0974A01FF](/claim/clm_E0A0974A01FF.md) - 2011-11-23 to 2012-02-22 | shares_outstanding | 297,248,622 shares | superseded | [clm_F2E28980F732](/claim/clm_F2E28980F732.md) ## 2012 - 2012-01-31 to 2012-04-30 | quarterly_operating_income | 192,000,000 United States dollar | superseded | [clm_29102F345100](/claim/clm_29102F345100.md) - 2012-01-31 to 2012-04-30 | quarterly_research_and_development | 168,000,000 United States dollar | superseded | [clm_6DEBEB6E25F9](/claim/clm_6DEBEB6E25F9.md) - 2012-01-31 to 2012-04-30 | cash_and_equivalents | 277,000,000 United States dollar | superseded | [clm_870E3B2C8189](/claim/clm_870E3B2C8189.md) - 2012-01-31 to 2012-04-30 | quarterly_net_income | 118,000,000 United States dollar | superseded | [clm_8DB06BA040EB](/claim/clm_8DB06BA040EB.md) - 2012-01-31 to 2012-04-30 | total_equity | 2,223,000,000 United States dollar | superseded | [clm_9D1865FB5BD7](/claim/clm_9D1865FB5BD7.md) - 2012-01-31 to 2012-04-30 | total_assets | 4,962,000,000 United States dollar | superseded | [clm_B43556CDBF32](/claim/clm_B43556CDBF32.md) - 2012-01-31 to 2012-04-30 | quarterly_revenue | 1,019,000,000 United States dollar | superseded | [clm_B65176387A21](/claim/clm_B65176387A21.md) - 2012-02-22 to 2012-05-18 | shares_outstanding | 294,908,350 shares | superseded | [clm_2B0652BD78D8](/claim/clm_2B0652BD78D8.md) - 2012-04-30 to 2012-07-31 | cash_and_equivalents | 859,000,000 United States dollar | superseded | [clm_5AE9F12901FF](/claim/clm_5AE9F12901FF.md) - 2012-04-30 to 2012-10-31 | quarterly_operating_income | 1,107,000,000 United States dollar | superseded | [clm_7508CB7291F3](/claim/clm_7508CB7291F3.md) - 2012-04-30 to 2012-07-31 | total_equity | 2,835,000,000 United States dollar | superseded | [clm_9899D7AFA865](/claim/clm_9899D7AFA865.md) - 2012-04-30 to 2012-07-31 | total_assets | 5,116,000,000 United States dollar | superseded | [clm_BDDA602FA6BF](/claim/clm_BDDA602FA6BF.md) - 2012-04-30 to 2012-10-31 | quarterly_net_income | 734,000,000 United States dollar | superseded | [clm_D5500913742D](/claim/clm_D5500913742D.md) - 2012-04-30 to 2012-10-31 | quarterly_revenue | 1,945,000,000 United States dollar | superseded | [clm_FB8F0E3A11A0](/claim/clm_FB8F0E3A11A0.md) - 2012-05-18 to 2012-08-31 | shares_outstanding | 293,668,960 shares | superseded | [clm_2FCE2D546874](/claim/clm_2FCE2D546874.md) - 2012-07-31 to 2012-10-31 | total_assets | 4,684,000,000 United States dollar | superseded | [clm_1DB9DC2C78AA](/claim/clm_1DB9DC2C78AA.md) - 2012-07-31 to 2012-08-01 | operating_income | 1,177,000,000 United States dollar | superseded | [clm_2247935498CA](/claim/clm_2247935498CA.md) - 2012-07-31 to 2012-08-01 | net_income | 792,000,000 United States dollar | superseded | [clm_31BD852C0675](/claim/clm_31BD852C0675.md) - 2012-07-31 to 2013-07-31 | research_and_development | 669,000,000 United States dollar | superseded | [clm_496DC0FC5CFE](/claim/clm_496DC0FC5CFE.md) - 2012-07-31 to 2012-08-01 | revenue | 4,151,000,000 United States dollar | superseded | [clm_91424A4BE667](/claim/clm_91424A4BE667.md) - 2012-07-31 to 2012-10-31 | total_equity | 2,744,000,000 United States dollar | superseded | [clm_ED0B962FC4AB](/claim/clm_ED0B962FC4AB.md) - 2012-07-31 to 2012-10-31 | cash_and_equivalents | 393,000,000 United States dollar | superseded | [clm_FBFDAF7FC8E1](/claim/clm_FBFDAF7FC8E1.md) - 2012-08-01 to 2013-07-31 | operating_income | 1,233,000,000 United States dollar | superseded | [clm_1354B9E77F35](/claim/clm_1354B9E77F35.md) - 2012-08-01 to 2013-07-31 | net_income | 858,000,000 United States dollar | superseded | [clm_C2E3A99B0BF3](/claim/clm_C2E3A99B0BF3.md) - 2012-08-31 to 2012-11-20 | shares_outstanding | 295,371,402 shares | superseded | [clm_A7FCD5677F92](/claim/clm_A7FCD5677F92.md) - 2012-10-31 to 2013-01-31 | quarterly_net_income | -19,000,000 United States dollar | superseded | [clm_1D9E4E6C36FD](/claim/clm_1D9E4E6C36FD.md) - 2012-10-31 to 2013-01-31 | cash_and_equivalents | 216,000,000 United States dollar | superseded | [clm_22F6C7929F95](/claim/clm_22F6C7929F95.md) - 2012-10-31 to 2013-01-31 | total_equity | 2,745,000,000 United States dollar | superseded | [clm_3FD911ED4732](/claim/clm_3FD911ED4732.md) - 2012-10-31 to 2013-01-31 | quarterly_operating_income | -69,000,000 United States dollar | superseded | [clm_AB26FF8877C5](/claim/clm_AB26FF8877C5.md) - 2012-10-31 to 2013-01-31 | quarterly_research_and_development | 178,000,000 United States dollar | superseded | [clm_C21DA511E00B](/claim/clm_C21DA511E00B.md) - 2012-10-31 to 2013-01-31 | quarterly_revenue | 647,000,000 United States dollar | superseded | [clm_D9832B864E8D](/claim/clm_D9832B864E8D.md) - 2012-10-31 to 2013-01-31 | total_assets | 4,494,000,000 United States dollar | superseded | [clm_E5DD207FAEC0](/claim/clm_E5DD207FAEC0.md) - 2012-11-20 to 2013-02-22 | shares_outstanding | 296,053,798 shares | superseded | [clm_1CDB3BE78523](/claim/clm_1CDB3BE78523.md) ## 2013 - 2013-01-31 to 2013-04-30 | total_equity | 2,792,000,000 United States dollar | superseded | [clm_10A28E23B1B4](/claim/clm_10A28E23B1B4.md) - 2013-01-31 to 2013-04-30 | quarterly_revenue | 968,000,000 United States dollar | superseded | [clm_3FD0F2238F44](/claim/clm_3FD0F2238F44.md) - 2013-01-31 to 2013-04-30 | quarterly_net_income | 71,000,000 United States dollar | superseded | [clm_45AABA098C50](/claim/clm_45AABA098C50.md) - 2013-01-31 to 2013-04-30 | quarterly_operating_income | 93,000,000 United States dollar | superseded | [clm_9708B722B6C3](/claim/clm_9708B722B6C3.md) - 2013-01-31 to 2013-04-30 | quarterly_research_and_development | 179,000,000 United States dollar | superseded | [clm_B4B73E167E43](/claim/clm_B4B73E167E43.md) - 2013-01-31 to 2013-04-30 | total_assets | 5,089,000,000 United States dollar | superseded | [clm_C8D1FFBAE835](/claim/clm_C8D1FFBAE835.md) - 2013-01-31 to 2013-04-30 | cash_and_equivalents | 399,000,000 United States dollar | superseded | [clm_DCC7F5C42515](/claim/clm_DCC7F5C42515.md) - 2013-02-22 to 2013-05-23 | shares_outstanding | 296,388,841 shares | superseded | [clm_2385F4E1D3A6](/claim/clm_2385F4E1D3A6.md) - 2013-04-30 to 2013-10-31 | quarterly_revenue | 2,178,000,000 United States dollar | superseded | [clm_39ABBCB0B691](/claim/clm_39ABBCB0B691.md) - 2013-04-30 to 2013-07-31 | total_assets | 5,810,000,000 United States dollar | superseded | [clm_4386DA52383C](/claim/clm_4386DA52383C.md) - 2013-04-30 to 2013-10-31 | quarterly_operating_income | 1,247,000,000 United States dollar | superseded | [clm_58B160F0AF5A](/claim/clm_58B160F0AF5A.md) - 2013-04-30 to 2013-07-31 | cash_and_equivalents | 1,412,000,000 United States dollar | superseded | [clm_6737159E81C8](/claim/clm_6737159E81C8.md) - 2013-04-30 to 2013-07-31 | total_equity | 3,570,000,000 United States dollar | superseded | [clm_68C52BAEB487](/claim/clm_68C52BAEB487.md) - 2013-04-30 to 2013-10-31 | quarterly_net_income | 822,000,000 United States dollar | superseded | [clm_9BE50F899EF3](/claim/clm_9BE50F899EF3.md) - 2013-04-30 to 2013-10-31 | quarterly_research_and_development | 177,000,000 United States dollar | superseded | [clm_A4228838B0AC](/claim/clm_A4228838B0AC.md) - 2013-05-23 to 2013-08-30 | shares_outstanding | 296,925,259 shares | superseded | [clm_90F33F8959C5](/claim/clm_90F33F8959C5.md) - 2013-07-31 to 2013-10-31 | cash_and_equivalents | 1,009,000,000 United States dollar | superseded | [clm_0F14DA717366](/claim/clm_0F14DA717366.md) - 2013-07-31 to 2013-08-01 | revenue | 4,171,000,000 United States dollar | superseded | [clm_29373CF41B15](/claim/clm_29373CF41B15.md) - 2013-07-31 to 2013-10-31 | total_assets | 5,486,000,000 United States dollar | superseded | [clm_43805594E97F](/claim/clm_43805594E97F.md) - 2013-07-31 to 2013-08-01 | net_income | 858,000,000 United States dollar | superseded | [clm_6E6B8DE63744](/claim/clm_6E6B8DE63744.md) - 2013-07-31 to 2014-07-31 | research_and_development | 685,000,000 United States dollar | superseded | [clm_7B1AF742EA25](/claim/clm_7B1AF742EA25.md) - 2013-07-31 to 2013-08-01 | operating_income | 1,233,000,000 United States dollar | superseded | [clm_872CF6DAEBFE](/claim/clm_872CF6DAEBFE.md) - 2013-07-31 to 2013-10-31 | total_equity | 3,531,000,000 United States dollar | superseded | [clm_C03B72DB1401](/claim/clm_C03B72DB1401.md) - 2013-08-01 to 2014-07-31 | revenue | 4,506,000,000 United States dollar | superseded | [clm_22F9560E0964](/claim/clm_22F9560E0964.md) - 2013-08-01 to 2014-07-31 | net_income | 907,000,000 United States dollar | superseded | [clm_581B5C9DD2D7](/claim/clm_581B5C9DD2D7.md) - 2013-08-01 to 2014-07-31 | operating_income | 1,314,000,000 United States dollar | superseded | [clm_EA03DF85EF3E](/claim/clm_EA03DF85EF3E.md) - 2013-08-30 to 2013-11-18 | shares_outstanding | 282,712,839 shares | superseded | [clm_0221841A3379](/claim/clm_0221841A3379.md) - 2013-10-31 to 2014-01-31 | quarterly_research_and_development | 176,000,000 United States dollar | superseded | [clm_0144BC178EF6](/claim/clm_0144BC178EF6.md) - 2013-10-31 to 2014-01-31 | cash_and_equivalents | 417,000,000 United States dollar | superseded | [clm_0EE7F6594744](/claim/clm_0EE7F6594744.md) - 2013-10-31 to 2014-01-31 | quarterly_revenue | 622,000,000 United States dollar | superseded | [clm_145834B620EE](/claim/clm_145834B620EE.md) - 2013-10-31 to 2014-01-31 | quarterly_operating_income | -77,000,000 United States dollar | superseded | [clm_21180A4D3FE9](/claim/clm_21180A4D3FE9.md) - 2013-10-31 to 2014-01-31 | quarterly_net_income | -11,000,000 United States dollar | superseded | [clm_2787013411D7](/claim/clm_2787013411D7.md) - 2013-10-31 to 2014-01-31 | total_assets | 4,068,000,000 United States dollar | superseded | [clm_3D54736DC3E6](/claim/clm_3D54736DC3E6.md) - 2013-10-31 to 2014-01-31 | total_equity | 2,224,000,000 United States dollar | superseded | [clm_C00E820D9A45](/claim/clm_C00E820D9A45.md) - 2013-11-18 to 2014-02-17 | shares_outstanding | 284,852,965 shares | superseded | [clm_11DB3604A240](/claim/clm_11DB3604A240.md) ## 2014 - 2014-01-31 to 2014-04-30 | total_equity | 2,235,000,000 United States dollar | superseded | [clm_11C69C02B3D2](/claim/clm_11C69C02B3D2.md) - 2014-01-31 to 2014-04-30 | quarterly_research_and_development | 186,000,000 United States dollar | superseded | [clm_28CD3DFE0F5A](/claim/clm_28CD3DFE0F5A.md) - 2014-01-31 to 2014-04-30 | quarterly_operating_income | -46,000,000 United States dollar | superseded | [clm_54FBB5CCA328](/claim/clm_54FBB5CCA328.md) - 2014-01-31 to 2014-04-30 | total_assets | 4,718,000,000 United States dollar | superseded | [clm_7418EA935060](/claim/clm_7418EA935060.md) - 2014-01-31 to 2014-04-30 | quarterly_net_income | -37,000,000 United States dollar | superseded | [clm_80E4CDB717FF](/claim/clm_80E4CDB717FF.md) - 2014-01-31 to 2014-04-30 | quarterly_revenue | 782,000,000 United States dollar | superseded | [clm_CA3CB8E0A137](/claim/clm_CA3CB8E0A137.md) - 2014-01-31 to 2014-04-30 | cash_and_equivalents | 625,000,000 United States dollar | superseded | [clm_FFF34A17CD1C](/claim/clm_FFF34A17CD1C.md) - 2014-02-17 to 2014-05-14 | shares_outstanding | 283,313,817 shares | superseded | [clm_E6CF25D60D71](/claim/clm_E6CF25D60D71.md) - 2014-04-30 to 2014-07-31 | total_assets | 5,610,000,000 United States dollar | superseded | [clm_176FF08687D5](/claim/clm_176FF08687D5.md) - 2014-04-30 to 2014-10-31 | quarterly_operating_income | 1,494,000,000 United States dollar | superseded | [clm_2D1FC40C8535](/claim/clm_2D1FC40C8535.md) - 2014-04-30 to 2014-10-31 | quarterly_net_income | 984,000,000 United States dollar | superseded | [clm_3188381616AF](/claim/clm_3188381616AF.md) - 2014-04-30 to 2014-07-31 | total_equity | 3,238,000,000 United States dollar | superseded | [clm_66EC054E601B](/claim/clm_66EC054E601B.md) - 2014-04-30 to 2014-07-31 | cash_and_equivalents | 1,574,000,000 United States dollar | superseded | [clm_BADC678A90C5](/claim/clm_BADC678A90C5.md) - 2014-04-30 to 2014-10-31 | quarterly_revenue | 2,388,000,000 United States dollar | superseded | [clm_E3BA54FDDD97](/claim/clm_E3BA54FDDD97.md) - 2014-05-14 to 2014-08-29 | shares_outstanding | 283,886,921 shares | superseded | [clm_131152BD1267](/claim/clm_131152BD1267.md) - 2014-07-31 to 2014-10-31 | total_equity | 3,078,000,000 United States dollar | superseded | [clm_20DB2733379E](/claim/clm_20DB2733379E.md) - 2014-07-31 to 2014-08-01 | revenue | 4,506,000,000 United States dollar | superseded | [clm_3D1FE9D40274](/claim/clm_3D1FE9D40274.md) - 2014-07-31 to 2014-08-01 | net_income | 907,000,000 United States dollar | superseded | [clm_7F97B080998F](/claim/clm_7F97B080998F.md) - 2014-07-31 to 2014-10-31 | cash_and_equivalents | 849,000,000 United States dollar | superseded | [clm_9182CE9523B0](/claim/clm_9182CE9523B0.md) - 2014-07-31 to 2015-07-31 | research_and_development | 758,000,000 United States dollar | superseded | [clm_A9E2724BFBB3](/claim/clm_A9E2724BFBB3.md) - 2014-07-31 to 2014-08-01 | operating_income | 1,314,000,000 United States dollar | superseded | [clm_C25703B075D9](/claim/clm_C25703B075D9.md) - 2014-07-31 to 2014-10-31 | total_assets | 5,201,000,000 United States dollar | superseded | [clm_FD0097E00BEE](/claim/clm_FD0097E00BEE.md) - 2014-08-01 to 2015-07-31 | revenue | 4,192,000,000 United States dollar | superseded | [clm_721AD17F198E](/claim/clm_721AD17F198E.md) - 2014-08-01 to 2015-07-31 | operating_income | 738,000,000 United States dollar | superseded | [clm_7C0AFF92B6F3](/claim/clm_7C0AFF92B6F3.md) - 2014-08-01 to 2015-07-31 | net_income | 365,000,000 United States dollar | superseded | [clm_C3D3BB40356A](/claim/clm_C3D3BB40356A.md) - 2014-08-29 to 2014-11-14 | shares_outstanding | 285,540,169 shares | superseded | [clm_92E46C3B5D80](/claim/clm_92E46C3B5D80.md) - 2014-10-31 to 2015-01-31 | cash_and_equivalents | 542,000,000 United States dollar | superseded | [clm_01C32DAA17AC](/claim/clm_01C32DAA17AC.md) - 2014-10-31 to 2015-01-31 | quarterly_net_income | -84,000,000 United States dollar | superseded | [clm_059D53849A98](/claim/clm_059D53849A98.md) - 2014-10-31 to 2015-01-31 | total_equity | 2,927,000,000 United States dollar | superseded | [clm_0AF5220C6CF0](/claim/clm_0AF5220C6CF0.md) - 2014-10-31 to 2015-01-31 | quarterly_research_and_development | 200,000,000 United States dollar | superseded | [clm_354C5DA86A33](/claim/clm_354C5DA86A33.md) - 2014-10-31 to 2015-01-31 | total_assets | 5,038,000,000 United States dollar | superseded | [clm_650C4D9B157D](/claim/clm_650C4D9B157D.md) - 2014-10-31 to 2015-01-31 | quarterly_revenue | 672,000,000 United States dollar | superseded | [clm_E23CCBE22A83](/claim/clm_E23CCBE22A83.md) - 2014-10-31 to 2015-01-31 | quarterly_operating_income | -114,000,000 United States dollar | superseded | [clm_F62258134136](/claim/clm_F62258134136.md) - 2014-11-14 to 2015-02-17 | shares_outstanding | 285,496,420 shares | superseded | [clm_5B2FD3C8FCC4](/claim/clm_5B2FD3C8FCC4.md) ## 2015 - 2015-01-31 to 2015-04-30 | cash_and_equivalents | 482,000,000 United States dollar | superseded | [clm_115B08C65C42](/claim/clm_115B08C65C42.md) - 2015-01-31 to 2015-04-30 | quarterly_revenue | 808,000,000 United States dollar | superseded | [clm_2E20038E0FCC](/claim/clm_2E20038E0FCC.md) - 2015-01-31 to 2015-04-30 | quarterly_net_income | -66,000,000 United States dollar | superseded | [clm_559B5F2DB3E4](/claim/clm_559B5F2DB3E4.md) - 2015-01-31 to 2015-04-30 | total_equity | 2,354,000,000 United States dollar | superseded | [clm_A4EE74CBB789](/claim/clm_A4EE74CBB789.md) - 2015-01-31 to 2015-04-30 | quarterly_operating_income | -98,000,000 United States dollar | superseded | [clm_EAD6BCCBA94C](/claim/clm_EAD6BCCBA94C.md) - 2015-01-31 to 2015-04-30 | total_assets | 5,245,000,000 United States dollar | superseded | [clm_F17800196ADA](/claim/clm_F17800196ADA.md) - 2015-02-17 to 2015-05-18 | shares_outstanding | 276,726,077 shares | superseded | [clm_4DEA5BC48465](/claim/clm_4DEA5BC48465.md) - 2015-04-30 to 2015-07-31 | total_assets | 5,295,000,000 United States dollar | superseded | [clm_076C9100D11E](/claim/clm_076C9100D11E.md) - 2015-04-30 to 2015-10-31 | quarterly_revenue | 2,194,000,000 United States dollar | superseded | [clm_0AC33ABF26E7](/claim/clm_0AC33ABF26E7.md) - 2015-04-30 to 2015-10-31 | quarterly_research_and_development | 217,000,000 United States dollar | superseded | [clm_0B893E848838](/claim/clm_0B893E848838.md) - 2015-04-30 to 2015-07-31 | total_equity | 2,321,000,000 United States dollar | superseded | [clm_255D33E4F36D](/claim/clm_255D33E4F36D.md) - 2015-04-30 to 2015-10-31 | quarterly_operating_income | 906,000,000 United States dollar | superseded | [clm_7F39CBBD0630](/claim/clm_7F39CBBD0630.md) - 2015-04-30 to 2015-07-31 | cash_and_equivalents | 1,193,000,000 United States dollar | superseded | [clm_96C4C7F88A3D](/claim/clm_96C4C7F88A3D.md) - 2015-04-30 to 2015-10-31 | quarterly_net_income | 501,000,000 United States dollar | superseded | [clm_F3896803238F](/claim/clm_F3896803238F.md) - 2015-05-18 to 2015-08-24 | shares_outstanding | 275,668,858 shares | superseded | [clm_9EBF17440266](/claim/clm_9EBF17440266.md) - 2015-07-31 to 2015-08-01 | net_income | 365,000,000 United States dollar | superseded | [clm_2516E577EF5C](/claim/clm_2516E577EF5C.md) - 2015-07-31 to 2015-10-31 | total_equity | 2,332,000,000 United States dollar | superseded | [clm_5820C2CF3A5A](/claim/clm_5820C2CF3A5A.md) - 2015-07-31 to 2015-08-01 | revenue | 4,192,000,000 United States dollar | superseded | [clm_7EE3BF938271](/claim/clm_7EE3BF938271.md) - 2015-07-31 to 2015-10-31 | cash_and_equivalents | 808,000,000 United States dollar | superseded | [clm_8627CCE66EDF](/claim/clm_8627CCE66EDF.md) - 2015-07-31 to 2015-10-31 | total_assets | 4,968,000,000 United States dollar | superseded | [clm_8D23532A541E](/claim/clm_8D23532A541E.md) - 2015-07-31 to 2015-08-01 | operating_income | 738,000,000 United States dollar | superseded | [clm_A074E655BFA6](/claim/clm_A074E655BFA6.md) - 2015-07-31 to 2016-07-31 | research_and_development | 798,000,000 United States dollar | superseded | [clm_FC078D7863A0](/claim/clm_FC078D7863A0.md) - 2015-08-01 to 2016-07-31 | net_income | 979,000,000 United States dollar | superseded | [clm_9F4905F9A2F6](/claim/clm_9F4905F9A2F6.md) - 2015-08-01 to 2016-07-31 | revenue | 4,694,000,000 United States dollar | superseded | [clm_E35227BD648A](/claim/clm_E35227BD648A.md) - 2015-08-01 to 2016-07-31 | operating_income | 1,242,000,000 United States dollar | superseded | [clm_FB3125DE9162](/claim/clm_FB3125DE9162.md) - 2015-08-24 to 2015-11-16 | shares_outstanding | 277,306,606 shares | superseded | [clm_3EA67A992C09](/claim/clm_3EA67A992C09.md) - 2015-10-31 to 2016-01-31 | quarterly_net_income | -31,000,000 United States dollar | superseded | [clm_02046FE68158](/claim/clm_02046FE68158.md) - 2015-10-31 to 2016-01-31 | quarterly_operating_income | -29,000,000 United States dollar | superseded | [clm_893E2ADA2267](/claim/clm_893E2ADA2267.md) - 2015-10-31 to 2016-01-31 | total_assets | 3,833,000,000 United States dollar | superseded | [clm_BDAB28C9B5B8](/claim/clm_BDAB28C9B5B8.md) - 2015-10-31 to 2016-01-31 | cash_and_equivalents | 474,000,000 United States dollar | superseded | [clm_D42E79DA0938](/claim/clm_D42E79DA0938.md) - 2015-10-31 to 2016-01-31 | quarterly_revenue | 713,000,000 United States dollar | superseded | [clm_D9374A07AA89](/claim/clm_D9374A07AA89.md) - 2015-10-31 to 2016-01-31 | quarterly_research_and_development | 213,000,000 United States dollar | superseded | [clm_DB8E9FF2315A](/claim/clm_DB8E9FF2315A.md) - 2015-10-31 to 2016-01-31 | total_equity | 1,051,000,000 United States dollar | superseded | [clm_E5DEBD52FC2A](/claim/clm_E5DEBD52FC2A.md) - 2015-11-16 to 2016-02-19 | shares_outstanding | 264,004,330 shares | superseded | [clm_E52ECBD5F05B](/claim/clm_E52ECBD5F05B.md) ## 2016 - 2016-01-31 to 2016-04-30 | total_equity | 641,000,000 United States dollar | superseded | [clm_2BA8E0FBCA2D](/claim/clm_2BA8E0FBCA2D.md) - 2016-01-31 to 2016-04-30 | total_assets | 4,349,000,000 United States dollar | superseded | [clm_36AAF3679918](/claim/clm_36AAF3679918.md) - 2016-01-31 to 2016-04-30 | quarterly_revenue | 923,000,000 United States dollar | superseded | [clm_606FFC39EB2E](/claim/clm_606FFC39EB2E.md) - 2016-01-31 to 2016-04-30 | cash_and_equivalents | 334,000,000 United States dollar | superseded | [clm_6C1734260EFC](/claim/clm_6C1734260EFC.md) - 2016-01-31 to 2016-04-30 | quarterly_operating_income | 42,000,000 United States dollar | superseded | [clm_88DB0C33BC3E](/claim/clm_88DB0C33BC3E.md) - 2016-01-31 to 2016-04-30 | quarterly_net_income | 24,000,000 United States dollar | superseded | [clm_926C6D488596](/claim/clm_926C6D488596.md) - 2016-01-31 to 2016-04-30 | quarterly_research_and_development | 205,000,000 United States dollar | superseded | [clm_93915421DAE0](/claim/clm_93915421DAE0.md) - 2016-02-19 to 2016-05-18 | shares_outstanding | 256,821,224 shares | superseded | [clm_64E1AFAA1FD1](/claim/clm_64E1AFAA1FD1.md) - 2016-04-30 to 2016-10-31 | quarterly_net_income | 1,026,000,000 United States dollar | superseded | [clm_05D20BE0F2E3](/claim/clm_05D20BE0F2E3.md) - 2016-04-30 to 2016-07-31 | cash_and_equivalents | 1,289,000,000 United States dollar | superseded | [clm_0ABE9ADE6778](/claim/clm_0ABE9ADE6778.md) - 2016-04-30 to 2016-07-31 | total_assets | 4,940,000,000 United States dollar | superseded | [clm_691143AF0D9F](/claim/clm_691143AF0D9F.md) - 2016-04-30 to 2016-07-31 | total_equity | 1,248,000,000 United States dollar | superseded | [clm_BABC38CEA006](/claim/clm_BABC38CEA006.md) - 2016-04-30 to 2016-10-31 | quarterly_operating_income | 1,285,000,000 United States dollar | superseded | [clm_C99C6ACE987D](/claim/clm_C99C6ACE987D.md) - 2016-04-30 to 2016-10-31 | quarterly_revenue | 2,304,000,000 United States dollar | superseded | [clm_EA10AC440465](/claim/clm_EA10AC440465.md) - 2016-04-30 to 2016-10-31 | quarterly_research_and_development | 228,000,000 United States dollar | superseded | [clm_FCC2294476C6](/claim/clm_FCC2294476C6.md) - 2016-05-18 to 2016-08-25 | shares_outstanding | 255,871,261 shares | superseded | [clm_56A0E8CB6FAC](/claim/clm_56A0E8CB6FAC.md) - 2016-07-31 to 2016-08-01 | operating_income | 1,242,000,000 United States dollar | superseded | [clm_0B33E8C0AC56](/claim/clm_0B33E8C0AC56.md) - 2016-07-31 to 2016-10-31 | total_equity | 1,161,000,000 United States dollar | superseded | [clm_442FD729705D](/claim/clm_442FD729705D.md) - 2016-07-31 to 2016-08-01 | net_income | 979,000,000 United States dollar | superseded | [clm_744B01730005](/claim/clm_744B01730005.md) - 2016-07-31 to 2016-08-01 | revenue | 4,694,000,000 United States dollar | superseded | [clm_B300D5149788](/claim/clm_B300D5149788.md) - 2016-07-31 to 2016-10-31 | cash_and_equivalents | 638,000,000 United States dollar | superseded | [clm_D23C73D255AD](/claim/clm_D23C73D255AD.md) - 2016-07-31 to 2016-10-31 | total_assets | 4,250,000,000 United States dollar | superseded | [clm_E8BB5CB5897D](/claim/clm_E8BB5CB5897D.md) - 2016-07-31 to 2017-07-31 | research_and_development | 881,000,000 United States dollar | superseded | [clm_EC5022BD3C9D](/claim/clm_EC5022BD3C9D.md) - 2016-08-01 to 2017-07-31 | operating_income | 1,395,000,000 United States dollar | superseded | [clm_114EB119D3C4](/claim/clm_114EB119D3C4.md) - 2016-08-01 to 2017-07-31 | revenue | 5,177,000,000 United States dollar | superseded | [clm_B163ED45021B](/claim/clm_B163ED45021B.md) - 2016-08-25 to 2016-11-14 | shares_outstanding | 257,938,052 shares | superseded | [clm_9358BC0FFDD0](/claim/clm_9358BC0FFDD0.md) - 2016-10-31 to 2017-01-31 | quarterly_net_income | -30,000,000 United States dollar | superseded | [clm_3510B4978BE2](/claim/clm_3510B4978BE2.md) - 2016-10-31 to 2017-01-31 | total_equity | 936,000,000 United States dollar | superseded | [clm_473D6296631D](/claim/clm_473D6296631D.md) - 2016-10-31 to 2017-01-31 | quarterly_research_and_development | 246,000,000 United States dollar | superseded | [clm_500FE0709745](/claim/clm_500FE0709745.md) - 2016-10-31 to 2017-01-31 | total_assets | 3,933,000,000 United States dollar | superseded | [clm_8DEAD0A2FFB2](/claim/clm_8DEAD0A2FFB2.md) - 2016-10-31 to 2017-01-31 | quarterly_revenue | 778,000,000 United States dollar | superseded | [clm_9373D51AB125](/claim/clm_9373D51AB125.md) - 2016-10-31 to 2017-01-31 | cash_and_equivalents | 360,000,000 United States dollar | superseded | [clm_9C2534900D3B](/claim/clm_9C2534900D3B.md) - 2016-10-31 to 2017-01-31 | quarterly_operating_income | -61,000,000 United States dollar | superseded | [clm_C9D76B4C9C95](/claim/clm_C9D76B4C9C95.md) - 2016-11-14 to 2017-02-17 | shares_outstanding | 256,638,049 shares | superseded | [clm_20CC0ABAB81B](/claim/clm_20CC0ABAB81B.md) ## 2017 - 2017-01-31 to 2017-04-30 | total_equity | 785,000,000 United States dollar | superseded | [clm_11429760CC14](/claim/clm_11429760CC14.md) - 2017-01-31 to 2017-04-30 | quarterly_operating_income | 22,000,000 United States dollar | superseded | [clm_160DBD3D2305](/claim/clm_160DBD3D2305.md) - 2017-01-31 to 2017-04-30 | quarterly_net_income | 13,000,000 United States dollar | superseded | [clm_41CF9B69901E](/claim/clm_41CF9B69901E.md) - 2017-01-31 to 2017-04-30 | quarterly_revenue | 1,016,000,000 United States dollar | superseded | [clm_5A35B7C164E4](/claim/clm_5A35B7C164E4.md) - 2017-01-31 to 2017-04-30 | total_assets | 4,373,000,000 United States dollar | superseded | [clm_655D77F76621](/claim/clm_655D77F76621.md) - 2017-01-31 to 2017-04-30 | quarterly_research_and_development | 243,000,000 United States dollar | superseded | [clm_8052C9481938](/claim/clm_8052C9481938.md) - 2017-01-31 to 2017-04-30 | cash_and_equivalents | 392,000,000 United States dollar | superseded | [clm_B62A29ACC273](/claim/clm_B62A29ACC273.md) - 2017-02-17 to 2017-05-17 | shares_outstanding | 255,785,325 shares | superseded | [clm_2CAFA56D32CB](/claim/clm_2CAFA56D32CB.md) - 2017-04-30 to 2017-10-31 | quarterly_net_income | 964,000,000 United States dollar | superseded | [clm_04B26EA3197B](/claim/clm_04B26EA3197B.md) - 2017-04-30 to 2017-07-31 | total_equity | 1,697,000,000 United States dollar | superseded | [clm_351490658310](/claim/clm_351490658310.md) - 2017-04-30 to 2017-07-31 | total_assets | 4,969,000,000 United States dollar | superseded | [clm_69ADD01FAC9B](/claim/clm_69ADD01FAC9B.md) - 2017-04-30 to 2017-10-31 | quarterly_operating_income | 1,444,000,000 United States dollar | superseded | [clm_B96ACD332EB0](/claim/clm_B96ACD332EB0.md) - 2017-04-30 to 2017-10-31 | quarterly_revenue | 2,541,000,000 United States dollar | superseded | [clm_BC5C88DFB002](/claim/clm_BC5C88DFB002.md) - 2017-04-30 to 2017-07-31 | cash_and_equivalents | 1,350,000,000 United States dollar | superseded | [clm_F5C3F60AFA8E](/claim/clm_F5C3F60AFA8E.md) - 2017-05-17 to 2017-08-25 | shares_outstanding | 256,216,921 shares | superseded | [clm_DD020FA4DB2B](/claim/clm_DD020FA4DB2B.md) - 2017-07-31 to 2017-10-31 | total_assets | 4,068,000,000 United States dollar | superseded | [clm_5CD8954A84BF](/claim/clm_5CD8954A84BF.md) - 2017-07-31 to 2017-10-31 | total_equity | 1,354,000,000 United States dollar | superseded | [clm_750991396131](/claim/clm_750991396131.md) - 2017-07-31 to 2017-10-31 | cash_and_equivalents | 529,000,000 United States dollar | superseded | [clm_8E8A63222666](/claim/clm_8E8A63222666.md) - 2017-07-31 to 2018-07-31 | research_and_development | 998,000,000 United States dollar | superseded | [clm_B41DB4AEE1A7](/claim/clm_B41DB4AEE1A7.md) - 2017-07-31 to 2017-08-01 | net_income | 971,000,000 United States dollar | superseded | [clm_C2E6FBAB5EA5](/claim/clm_C2E6FBAB5EA5.md) - 2017-07-31 to 2017-08-01 | revenue | 5,177,000,000 United States dollar | superseded | [clm_F9716AD655E6](/claim/clm_F9716AD655E6.md) - 2017-07-31 to 2017-08-01 | operating_income | 1,395,000,000 United States dollar | superseded | [clm_FFD13E584488](/claim/clm_FFD13E584488.md) - 2017-08-01 to 2018-07-31 | revenue | 5,964,000,000 United States dollar | superseded | [clm_9947DDDC0008](/claim/clm_9947DDDC0008.md) - 2017-08-01 to 2018-07-31 | net_income | 1,211,000,000 United States dollar | superseded | [clm_D2196CC34EDA](/claim/clm_D2196CC34EDA.md) - 2017-08-01 to 2018-07-31 | operating_income | 1,497,000,000 United States dollar | superseded | [clm_FE946F3D89A7](/claim/clm_FE946F3D89A7.md) - 2017-08-25 to 2017-11-14 | shares_outstanding | 254,973,504 shares | superseded | [clm_5813DE6E32A9](/claim/clm_5813DE6E32A9.md) - 2017-10-31 to 2018-01-31 | quarterly_research_and_development | 293,000,000 United States dollar | superseded | [clm_0C671564E29E](/claim/clm_0C671564E29E.md) - 2017-10-31 to 2018-01-31 | cash_and_equivalents | 529,000,000 United States dollar | superseded | [clm_435A71C7FECB](/claim/clm_435A71C7FECB.md) - 2017-10-31 to 2018-01-31 | quarterly_operating_income | -57,000,000 United States dollar | superseded | [clm_4AD3C79654E1](/claim/clm_4AD3C79654E1.md) - 2017-10-31 to 2018-01-31 | quarterly_revenue | 910,000,000 United States dollar | superseded | [clm_825BCA2BCA2D](/claim/clm_825BCA2BCA2D.md) - 2017-10-31 to 2018-01-31 | quarterly_net_income | -17,000,000 United States dollar | superseded | [clm_B6408BEDA9A1](/claim/clm_B6408BEDA9A1.md) - 2017-10-31 to 2018-01-31 | total_equity | 1,203,000,000 United States dollar | superseded | [clm_EEF3DA50DF1C](/claim/clm_EEF3DA50DF1C.md) - 2017-10-31 to 2018-01-31 | total_assets | 4,064,000,000 United States dollar | superseded | [clm_F72FA30DF6EB](/claim/clm_F72FA30DF6EB.md) - 2017-11-14 to 2018-02-16 | shares_outstanding | 255,649,800 shares | superseded | [clm_CE6B1CEB4C0B](/claim/clm_CE6B1CEB4C0B.md) ## 2018 - 2018-01-31 to 2018-04-30 | quarterly_net_income | -21,000,000 United States dollar | superseded | [clm_207065DA7921](/claim/clm_207065DA7921.md) - 2018-01-31 to 2018-04-30 | quarterly_operating_income | 20,000,000 United States dollar | superseded | [clm_251581156F61](/claim/clm_251581156F61.md) - 2018-01-31 to 2018-04-30 | quarterly_research_and_development | 286,000,000 United States dollar | superseded | [clm_580B5A5A8FF9](/claim/clm_580B5A5A8FF9.md) - 2018-01-31 to 2018-04-30 | total_equity | 1,157,000,000 United States dollar | superseded | [clm_5A8E807B0816](/claim/clm_5A8E807B0816.md) - 2018-01-31 to 2018-04-30 | quarterly_revenue | 1,339,000,000 United States dollar | superseded | [clm_60C1517B9403](/claim/clm_60C1517B9403.md) - 2018-01-31 to 2018-04-30 | total_assets | 4,898,000,000 United States dollar | superseded | [clm_89792849315F](/claim/clm_89792849315F.md) - 2018-01-31 to 2018-04-30 | cash_and_equivalents | 478,000,000 United States dollar | superseded | [clm_9C9AE2EAA1A9](/claim/clm_9C9AE2EAA1A9.md) - 2018-02-16 to 2018-05-16 | shares_outstanding | 256,111,064 shares | superseded | [clm_02219A35671F](/claim/clm_02219A35671F.md) - 2018-04-30 to 2018-07-31 | total_assets | 5,787,000,000 United States dollar | superseded | [clm_0ECBFA692CFE](/claim/clm_0ECBFA692CFE.md) - 2018-04-30 to 2018-07-31 | total_equity | 2,364,000,000 United States dollar | superseded | [clm_3F6F1CE805E4](/claim/clm_3F6F1CE805E4.md) - 2018-04-30 to 2018-10-31 | quarterly_net_income | 1,200,000,000 United States dollar | superseded | [clm_7F1164BE6E25](/claim/clm_7F1164BE6E25.md) - 2018-04-30 to 2018-10-31 | quarterly_revenue | 2,912,000,000 United States dollar | superseded | [clm_80760FDBDBFD](/claim/clm_80760FDBDBFD.md) - 2018-04-30 to 2018-10-31 | quarterly_operating_income | 1,615,000,000 United States dollar | superseded | [clm_88A7E9F1A404](/claim/clm_88A7E9F1A404.md) - 2018-04-30 to 2018-07-31 | cash_and_equivalents | 1,614,000,000 United States dollar | superseded | [clm_BC3F1A442E23](/claim/clm_BC3F1A442E23.md) - 2018-04-30 to 2018-10-31 | quarterly_research_and_development | 296,000,000 United States dollar | superseded | [clm_C536E05D0A6F](/claim/clm_C536E05D0A6F.md) - 2018-05-16 to 2018-08-24 | shares_outstanding | 256,588,282 shares | superseded | [clm_E4BC07EE9A1C](/claim/clm_E4BC07EE9A1C.md) - 2018-07-31 to 2018-08-01 | net_income | 1,211,000,000 United States dollar | superseded | [clm_192ED1E837D1](/claim/clm_192ED1E837D1.md) - 2018-07-31 to 2018-10-31 | total_equity | 2,354,000,000 United States dollar | superseded | [clm_4E1114698057](/claim/clm_4E1114698057.md) - 2018-07-31 to 2018-10-31 | cash_and_equivalents | 1,464,000,000 United States dollar | superseded | [clm_6B22082756AA](/claim/clm_6B22082756AA.md) - 2018-07-31 to 2018-08-01 | revenue | 5,964,000,000 United States dollar | superseded | [clm_B0EC685F3935](/claim/clm_B0EC685F3935.md) - 2018-07-31 to 2018-10-31 | total_assets | 5,178,000,000 United States dollar | superseded | [clm_B7E42FBF0CD3](/claim/clm_B7E42FBF0CD3.md) - 2018-07-31 to 2018-08-01 | operating_income | 1,497,000,000 United States dollar | superseded | [clm_C8523B1117C0](/claim/clm_C8523B1117C0.md) - 2018-07-31 to 2019-07-31 | research_and_development | 1,186,000,000 United States dollar | superseded | [clm_FC892712269D](/claim/clm_FC892712269D.md) - 2018-08-01 to 2019-07-31 | revenue | 6,784,000,000 United States dollar | superseded | [clm_EBD82DE24AFC](/claim/clm_EBD82DE24AFC.md) - 2018-08-01 to 2019-07-31 | net_income | 1,557,000,000 United States dollar | superseded | [clm_EE01356D0C31](/claim/clm_EE01356D0C31.md) - 2018-08-01 to 2019-07-31 | operating_income | 1,854,000,000 United States dollar | superseded | [clm_EF716DBBE571](/claim/clm_EF716DBBE571.md) - 2018-08-24 to 2018-11-14 | shares_outstanding | 258,671,620 shares | superseded | [clm_BD605FEC36C9](/claim/clm_BD605FEC36C9.md) - 2018-10-31 to 2019-01-31 | quarterly_net_income | 34,000,000 United States dollar | superseded | [clm_005918A8CEC7](/claim/clm_005918A8CEC7.md) - 2018-10-31 to 2019-01-31 | cash_and_equivalents | 1,084,000,000 United States dollar | superseded | [clm_0BB81225C285](/claim/clm_0BB81225C285.md) - 2018-10-31 to 2019-01-31 | total_equity | 2,782,000,000 United States dollar | superseded | [clm_116344B5B6B4](/claim/clm_116344B5B6B4.md) - 2018-10-31 to 2019-01-31 | total_assets | 4,928,000,000 United States dollar | superseded | [clm_7E9D07F296BA](/claim/clm_7E9D07F296BA.md) - 2018-10-31 to 2019-01-31 | quarterly_operating_income | -10,000,000 United States dollar | superseded | [clm_B1878C1B3AC8](/claim/clm_B1878C1B3AC8.md) - 2018-10-31 to 2019-01-31 | quarterly_research_and_development | 294,000,000 United States dollar | superseded | [clm_B3EBE65269B7](/claim/clm_B3EBE65269B7.md) - 2018-11-14 to 2019-02-15 | shares_outstanding | 259,508,568 shares | superseded | [clm_FE9E271476D4](/claim/clm_FE9E271476D4.md) ## 2019 - 2019-01-31 to 2019-04-30 | quarterly_operating_income | 233,000,000 United States dollar | superseded | [clm_3364CD3FA310](/claim/clm_3364CD3FA310.md) - 2019-01-31 to 2019-04-30 | total_assets | 5,335,000,000 United States dollar | superseded | [clm_376845522AD1](/claim/clm_376845522AD1.md) - 2019-01-31 to 2019-04-30 | total_equity | 2,796,000,000 United States dollar | superseded | [clm_64E8B218DAB2](/claim/clm_64E8B218DAB2.md) - 2019-01-31 to 2019-04-30 | cash_and_equivalents | 1,075,000,000 United States dollar | superseded | [clm_795209B427FA](/claim/clm_795209B427FA.md) - 2019-01-31 to 2019-04-30 | quarterly_revenue | 1,502,000,000 United States dollar | superseded | [clm_7E9D9FB764DE](/claim/clm_7E9D9FB764DE.md) - 2019-01-31 to 2019-04-30 | quarterly_net_income | 189,000,000 United States dollar | superseded | [clm_8AE1EC32A078](/claim/clm_8AE1EC32A078.md) - 2019-01-31 to 2019-04-30 | quarterly_research_and_development | 295,000,000 United States dollar | superseded | [clm_A399E84479FB](/claim/clm_A399E84479FB.md) - 2019-02-15 to 2019-05-17 | shares_outstanding | 259,072,994 shares | superseded | [clm_B62B17CFE491](/claim/clm_B62B17CFE491.md) - 2019-04-30 to 2019-07-31 | total_assets | 6,917,000,000 United States dollar | superseded | [clm_027B39493374](/claim/clm_027B39493374.md) - 2019-04-30 to 2019-07-31 | cash_and_equivalents | 2,946,000,000 United States dollar | superseded | [clm_16FA75386038](/claim/clm_16FA75386038.md) - 2019-04-30 to 2019-10-31 | quarterly_net_income | 1,378,000,000 United States dollar | superseded | [clm_2D476B7D305A](/claim/clm_2D476B7D305A.md) - 2019-04-30 to 2019-10-31 | quarterly_revenue | 3,272,000,000 United States dollar | superseded | [clm_BE411826F72E](/claim/clm_BE411826F72E.md) - 2019-04-30 to 2019-10-31 | quarterly_operating_income | 1,784,000,000 United States dollar | superseded | [clm_CAEC3482A5D6](/claim/clm_CAEC3482A5D6.md) - 2019-04-30 to 2019-07-31 | total_equity | 4,070,000,000 United States dollar | superseded | [clm_DF7D1C7CAE9A](/claim/clm_DF7D1C7CAE9A.md) - 2019-04-30 to 2019-10-31 | quarterly_research_and_development | 311,000,000 United States dollar | superseded | [clm_FFFC0B17AA9E](/claim/clm_FFFC0B17AA9E.md) - 2019-05-17 to 2019-08-23 | shares_outstanding | 259,243,385 shares | superseded | [clm_2539A908C558](/claim/clm_2539A908C558.md) - 2019-07-31 to 2019-10-31 | total_equity | 3,749,000,000 United States dollar | superseded | [clm_2442EC905FC9](/claim/clm_2442EC905FC9.md) - 2019-07-31 to 2019-10-31 | total_assets | 6,283,000,000 United States dollar | superseded | [clm_5F8B21E70958](/claim/clm_5F8B21E70958.md) - 2019-07-31 to 2019-10-31 | cash_and_equivalents | 2,116,000,000 United States dollar | superseded | [clm_696E95D9915D](/claim/clm_696E95D9915D.md) - 2019-07-31 to 2019-08-01 | operating_income | 1,854,000,000 United States dollar | superseded | [clm_7B19954BB10C](/claim/clm_7B19954BB10C.md) - 2019-07-31 to 2019-08-01 | revenue | 6,784,000,000 United States dollar | superseded | [clm_BDAE7918B94D](/claim/clm_BDAE7918B94D.md) - 2019-07-31 to 2019-08-01 | net_income | 1,557,000,000 United States dollar | superseded | [clm_C2183488FFF1](/claim/clm_C2183488FFF1.md) - 2019-07-31 to 2020-07-31 | research_and_development | 1,233,000,000 United States dollar | superseded | [clm_E0A171FBD2C2](/claim/clm_E0A171FBD2C2.md) - 2019-08-01 to 2020-07-31 | net_income | 1,826,000,000 United States dollar | superseded | [clm_3CA25EDDB895](/claim/clm_3CA25EDDB895.md) - 2019-08-01 to 2020-07-31 | revenue | 7,679,000,000 United States dollar | superseded | [clm_441BCA05C6A8](/claim/clm_441BCA05C6A8.md) - 2019-08-01 to 2020-07-31 | operating_income | 2,176,000,000 United States dollar | superseded | [clm_628DF9765A7C](/claim/clm_628DF9765A7C.md) - 2019-08-23 to 2019-11-15 | shares_outstanding | 260,073,642 shares | superseded | [clm_6E502C561E65](/claim/clm_6E502C561E65.md) - 2019-10-31 to 2020-01-31 | quarterly_research_and_development | 334,000,000 United States dollar | superseded | [clm_2721F50C83B4](/claim/clm_2721F50C83B4.md) - 2019-10-31 to 2020-01-31 | quarterly_net_income | 57,000,000 United States dollar | superseded | [clm_5BD9DA5D707D](/claim/clm_5BD9DA5D707D.md) - 2019-10-31 to 2020-01-31 | quarterly_operating_income | 10,000,000 United States dollar | superseded | [clm_73121D9396AB](/claim/clm_73121D9396AB.md) - 2019-10-31 to 2020-01-31 | total_assets | 6,183,000,000 United States dollar | superseded | [clm_7723FDD894B1](/claim/clm_7723FDD894B1.md) - 2019-10-31 to 2020-01-31 | total_equity | 3,633,000,000 United States dollar | superseded | [clm_AC3617E448E2](/claim/clm_AC3617E448E2.md) - 2019-10-31 to 2020-01-31 | quarterly_revenue | 1,165,000,000 United States dollar | superseded | [clm_D025F1F54419](/claim/clm_D025F1F54419.md) - 2019-10-31 to 2020-01-31 | cash_and_equivalents | 1,630,000,000 United States dollar | superseded | [clm_DD1D99B2BA0D](/claim/clm_DD1D99B2BA0D.md) - 2019-11-15 to 2020-02-18 | shares_outstanding | 260,300,339 shares | superseded | [clm_DA833512ABB8](/claim/clm_DA833512ABB8.md) ## 2020 - 2020-01-31 to 2020-04-30 | quarterly_revenue | 1,696,000,000 United States dollar | superseded | [clm_1C0DD75C5283](/claim/clm_1C0DD75C5283.md) - 2020-01-31 to 2020-04-30 | total_equity | 3,727,000,000 United States dollar | superseded | [clm_4399E6A30B08](/claim/clm_4399E6A30B08.md) - 2020-01-31 to 2020-04-30 | cash_and_equivalents | 1,641,000,000 United States dollar | superseded | [clm_4D3A1470087D](/claim/clm_4D3A1470087D.md) - 2020-01-31 to 2020-04-30 | total_assets | 6,701,000,000 United States dollar | superseded | [clm_78BBDAAD03B2](/claim/clm_78BBDAAD03B2.md) - 2020-01-31 to 2020-04-30 | quarterly_net_income | 240,000,000 United States dollar | superseded | [clm_925B3A5C617F](/claim/clm_925B3A5C617F.md) - 2020-01-31 to 2020-04-30 | quarterly_research_and_development | 333,000,000 United States dollar | superseded | [clm_A5E602F55303](/claim/clm_A5E602F55303.md) - 2020-01-31 to 2020-04-30 | quarterly_operating_income | 270,000,000 United States dollar | superseded | [clm_D8D7A0A7830E](/claim/clm_D8D7A0A7830E.md) - 2020-02-18 to 2020-05-15 | shares_outstanding | 260,489,463 shares | superseded | [clm_66A3815D7CED](/claim/clm_66A3815D7CED.md) - 2020-04-30 to 2020-07-31 | total_assets | 7,764,000,000 United States dollar | superseded | [clm_0C20A5028A97](/claim/clm_0C20A5028A97.md) - 2020-04-30 to 2020-10-31 | quarterly_revenue | 3,002,000,000 United States dollar | superseded | [clm_1B1311202CF1](/claim/clm_1B1311202CF1.md) - 2020-04-30 to 2020-10-31 | quarterly_operating_income | 1,413,000,000 United States dollar | superseded | [clm_4F52B60E4EC2](/claim/clm_4F52B60E4EC2.md) - 2020-04-30 to 2020-10-31 | quarterly_net_income | 1,084,000,000 United States dollar | superseded | [clm_7785225F48AF](/claim/clm_7785225F48AF.md) - 2020-04-30 to 2020-07-31 | total_equity | 4,740,000,000 United States dollar | superseded | [clm_83FD4F04BB05](/claim/clm_83FD4F04BB05.md) - 2020-04-30 to 2020-07-31 | cash_and_equivalents | 3,371,000,000 United States dollar | superseded | [clm_AFD09A80997C](/claim/clm_AFD09A80997C.md) - 2020-04-30 to 2020-10-31 | quarterly_research_and_development | 332,000,000 United States dollar | superseded | [clm_D0F9689CF187](/claim/clm_D0F9689CF187.md) - 2020-05-15 to 2020-08-24 | shares_outstanding | 260,771,340 shares | superseded | [clm_55C3D31470F8](/claim/clm_55C3D31470F8.md) - 2020-07-31 to 2021-07-31 | research_and_development | 1,392,000,000 United States dollar | superseded | [clm_5844F0388C08](/claim/clm_5844F0388C08.md) - 2020-07-31 to 2020-08-01 | operating_income | 2,176,000,000 United States dollar | superseded | [clm_758BBDC12BE0](/claim/clm_758BBDC12BE0.md) - 2020-07-31 to 2020-10-31 | total_assets | 10,931,000,000 United States dollar | superseded | [clm_8C5BFE0B3904](/claim/clm_8C5BFE0B3904.md) - 2020-07-31 to 2020-10-31 | total_equity | 5,106,000,000 United States dollar | superseded | [clm_AF9B13D08F68](/claim/clm_AF9B13D08F68.md) - 2020-07-31 to 2020-10-31 | cash_and_equivalents | 6,442,000,000 United States dollar | superseded | [clm_B7F6BCFEBF01](/claim/clm_B7F6BCFEBF01.md) - 2020-07-31 to 2020-08-01 | revenue | 7,679,000,000 United States dollar | superseded | [clm_C6F841FBF8F1](/claim/clm_C6F841FBF8F1.md) - 2020-07-31 to 2020-08-01 | net_income | 1,826,000,000 United States dollar | superseded | [clm_FCE67B0E8A7A](/claim/clm_FCE67B0E8A7A.md) - 2020-08-01 to 2021-07-31 | operating_income | 2,500,000,000 United States dollar | superseded | [clm_0097ED94046A](/claim/clm_0097ED94046A.md) - 2020-08-01 to 2021-07-31 | revenue | 9,633,000,000 United States dollar | superseded | [clm_08D91F2DEB2B](/claim/clm_08D91F2DEB2B.md) - 2020-08-01 to 2021-07-31 | net_income | 2,062,000,000 United States dollar | superseded | [clm_532CCAB1EBB1](/claim/clm_532CCAB1EBB1.md) - 2020-08-24 to 2020-11-13 | shares_outstanding | 261,807,204 shares | superseded | [clm_59FFA1BA0C6E](/claim/clm_59FFA1BA0C6E.md) - 2020-10-31 to 2021-01-31 | total_assets | 9,707,000,000 United States dollar | superseded | [clm_305A50DA066C](/claim/clm_305A50DA066C.md) - 2020-10-31 to 2021-01-31 | total_equity | 5,245,000,000 United States dollar | superseded | [clm_78728EA257A0](/claim/clm_78728EA257A0.md) - 2020-10-31 to 2021-01-31 | quarterly_net_income | 198,000,000 United States dollar | superseded | [clm_7A3514EA6404](/claim/clm_7A3514EA6404.md) - 2020-10-31 to 2021-01-31 | quarterly_operating_income | 209,000,000 United States dollar | superseded | [clm_BE3718916552](/claim/clm_BE3718916552.md) - 2020-10-31 to 2021-01-31 | cash_and_equivalents | 5,174,000,000 United States dollar | superseded | [clm_D4182BBEF4DF](/claim/clm_D4182BBEF4DF.md) - 2020-10-31 to 2021-01-31 | quarterly_research_and_development | 325,000,000 United States dollar | superseded | [clm_EC3040E7598B](/claim/clm_EC3040E7598B.md) - 2020-10-31 to 2021-01-31 | quarterly_revenue | 1,323,000,000 United States dollar | superseded | [clm_FEF14FFA6996](/claim/clm_FEF14FFA6996.md) - 2020-11-13 to 2021-02-16 | shares_outstanding | 262,740,511 shares | superseded | [clm_8D73791DCF2F](/claim/clm_8D73791DCF2F.md) ## 2021 - 2021-01-31 to 2021-04-30 | quarterly_operating_income | -25,000,000 United States dollar | superseded | [clm_5C1D6F9BD73F](/claim/clm_5C1D6F9BD73F.md) - 2021-01-31 to 2021-04-30 | quarterly_net_income | 20,000,000 United States dollar | superseded | [clm_6B1DD90D7E5E](/claim/clm_6B1DD90D7E5E.md) - 2021-01-31 to 2021-04-30 | total_equity | 8,868,000,000 United States dollar | superseded | [clm_7DBBB2B6C5BB](/claim/clm_7DBBB2B6C5BB.md) - 2021-01-31 to 2021-04-30 | quarterly_revenue | 1,576,000,000 United States dollar | superseded | [clm_8580CFBB8D17](/claim/clm_8580CFBB8D17.md) - 2021-01-31 to 2021-04-30 | quarterly_research_and_development | 368,000,000 United States dollar | superseded | [clm_BF11BB707147](/claim/clm_BF11BB707147.md) - 2021-01-31 to 2021-04-30 | total_assets | 14,598,000,000 United States dollar | superseded | [clm_CC88326210A2](/claim/clm_CC88326210A2.md) - 2021-01-31 to 2021-04-30 | cash_and_equivalents | 1,952,000,000 United States dollar | superseded | [clm_D4215E0E22C3](/claim/clm_D4215E0E22C3.md) - 2021-02-16 to 2021-05-19 | shares_outstanding | 273,839,879 shares | superseded | [clm_9F757BB674CC](/claim/clm_9F757BB674CC.md) - 2021-04-30 to 2021-07-31 | total_assets | 15,758,000,000 United States dollar | superseded | [clm_09BE3E9C8902](/claim/clm_09BE3E9C8902.md) - 2021-04-30 to 2021-10-31 | quarterly_revenue | 4,173,000,000 United States dollar | superseded | [clm_521709CBC5D1](/claim/clm_521709CBC5D1.md) - 2021-04-30 to 2021-07-31 | total_equity | 9,955,000,000 United States dollar | superseded | [clm_7D06D1F6712F](/claim/clm_7D06D1F6712F.md) - 2021-04-30 to 2021-10-31 | quarterly_operating_income | 1,914,000,000 United States dollar | superseded | [clm_978538D886CD](/claim/clm_978538D886CD.md) - 2021-04-30 to 2021-07-31 | cash_and_equivalents | 3,164,000,000 United States dollar | superseded | [clm_AAF500254DB5](/claim/clm_AAF500254DB5.md) - 2021-04-30 to 2021-10-31 | quarterly_net_income | 1,464,000,000 United States dollar | superseded | [clm_B9BCC0B8BC26](/claim/clm_B9BCC0B8BC26.md) - 2021-04-30 to 2021-10-31 | quarterly_research_and_development | 464,000,000 United States dollar | superseded | [clm_D2F895EF8127](/claim/clm_D2F895EF8127.md) - 2021-05-19 to 2021-08-31 | shares_outstanding | 273,259,266 shares | superseded | [clm_BD7F8225432C](/claim/clm_BD7F8225432C.md) - 2021-07-31 to 2021-08-01 | operating_income | 2,500,000,000 United States dollar | superseded | [clm_2681613DE0DB](/claim/clm_2681613DE0DB.md) - 2021-07-31 to 2022-07-31 | research_and_development | 1,678,000,000 United States dollar | superseded | [clm_2E39749659A6](/claim/clm_2E39749659A6.md) - 2021-07-31 to 2021-10-31 | cash_and_equivalents | 2,562,000,000 United States dollar | superseded | [clm_39D2E09245D3](/claim/clm_39D2E09245D3.md) - 2021-07-31 to 2021-08-01 | net_income | 2,062,000,000 United States dollar | superseded | [clm_8C61E2D70C76](/claim/clm_8C61E2D70C76.md) - 2021-07-31 to 2021-08-01 | revenue | 9,633,000,000 United States dollar | superseded | [clm_A1E7ABB9E879](/claim/clm_A1E7ABB9E879.md) - 2021-07-31 to 2021-10-31 | total_assets | 15,516,000,000 United States dollar | superseded | [clm_DF89C7764A0E](/claim/clm_DF89C7764A0E.md) - 2021-07-31 to 2021-10-31 | total_equity | 9,869,000,000 United States dollar | superseded | [clm_E0DB4C8BD14B](/claim/clm_E0DB4C8BD14B.md) - 2021-08-01 to 2022-07-31 | revenue | 12,726,000,000 United States dollar | superseded | [clm_97794129A898](/claim/clm_97794129A898.md) - 2021-08-01 to 2022-07-31 | operating_income | 2,571,000,000 United States dollar | superseded | [clm_BD680AC27319](/claim/clm_BD680AC27319.md) - 2021-08-31 to 2021-11-12 | shares_outstanding | 273,091,929 shares | superseded | [clm_E751795F838E](/claim/clm_E751795F838E.md) - 2021-10-31 to 2022-01-31 | quarterly_research_and_development | 530,000,000 United States dollar | superseded | [clm_48A464370AF7](/claim/clm_48A464370AF7.md) - 2021-10-31 to 2022-01-31 | quarterly_revenue | 2,007,000,000 United States dollar | superseded | [clm_4E247E701344](/claim/clm_4E247E701344.md) - 2021-10-31 to 2022-01-31 | total_assets | 14,870,000,000 United States dollar | superseded | [clm_5761E31AFDB4](/claim/clm_5761E31AFDB4.md) - 2021-10-31 to 2022-01-31 | cash_and_equivalents | 2,864,000,000 United States dollar | superseded | [clm_57740C761AF2](/claim/clm_57740C761AF2.md) - 2021-10-31 to 2022-01-31 | total_equity | 9,733,000,000 United States dollar | superseded | [clm_944BB1A5CBDC](/claim/clm_944BB1A5CBDC.md) - 2021-10-31 to 2022-01-31 | quarterly_operating_income | 195,000,000 United States dollar | superseded | [clm_9BF32B2D39FD](/claim/clm_9BF32B2D39FD.md) - 2021-10-31 to 2022-01-31 | quarterly_net_income | 228,000,000 United States dollar | superseded | [clm_A484C13BD8A5](/claim/clm_A484C13BD8A5.md) - 2021-11-12 to 2022-02-18 | shares_outstanding | 283,168,410 shares | superseded | [clm_E08BE24AF3D7](/claim/clm_E08BE24AF3D7.md) ## 2022 - 2022-01-31 to 2022-04-30 | quarterly_operating_income | 56,000,000 United States dollar | superseded | [clm_1E4C7C1C9631](/claim/clm_1E4C7C1C9631.md) - 2022-01-31 to 2022-04-30 | quarterly_net_income | 100,000,000 United States dollar | superseded | [clm_2E3D1DEFC40D](/claim/clm_2E3D1DEFC40D.md) - 2022-01-31 to 2022-04-30 | total_assets | 26,303,000,000 United States dollar | superseded | [clm_5E6907093D94](/claim/clm_5E6907093D94.md) - 2022-01-31 to 2022-04-30 | cash_and_equivalents | 1,257,000,000 United States dollar | superseded | [clm_78C3448B63AA](/claim/clm_78C3448B63AA.md) - 2022-01-31 to 2022-04-30 | total_equity | 15,595,000,000 United States dollar | superseded | [clm_94F798DB0BA0](/claim/clm_94F798DB0BA0.md) - 2022-01-31 to 2022-04-30 | quarterly_research_and_development | 590,000,000 United States dollar | superseded | [clm_C818AA303977](/claim/clm_C818AA303977.md) - 2022-01-31 to 2022-04-30 | quarterly_revenue | 2,673,000,000 United States dollar | superseded | [clm_FC4B2E34E8A8](/claim/clm_FC4B2E34E8A8.md) - 2022-02-18 to 2022-05-18 | shares_outstanding | 282,812,475 shares | superseded | [clm_36C8EB9F43CA](/claim/clm_36C8EB9F43CA.md) - 2022-04-30 to 2022-10-31 | quarterly_research_and_development | 600,000,000 United States dollar | superseded | [clm_056445077873](/claim/clm_056445077873.md) - 2022-04-30 to 2022-10-31 | quarterly_operating_income | 2,395,000,000 United States dollar | superseded | [clm_10D7306CAA0C](/claim/clm_10D7306CAA0C.md) - 2022-04-30 to 2022-10-31 | quarterly_revenue | 5,632,000,000 United States dollar | superseded | [clm_27FCF2DC2FB9](/claim/clm_27FCF2DC2FB9.md) - 2022-04-30 to 2022-10-31 | quarterly_net_income | 1,794,000,000 United States dollar | superseded | [clm_BF2198773D82](/claim/clm_BF2198773D82.md) - 2022-04-30 to 2022-07-31 | total_equity | 16,961,000,000 United States dollar | superseded | [clm_E6C595C6648B](/claim/clm_E6C595C6648B.md) - 2022-04-30 to 2022-07-31 | total_assets | 28,514,000,000 United States dollar | superseded | [clm_ECA92EEBD822](/claim/clm_ECA92EEBD822.md) - 2022-04-30 to 2022-07-31 | cash_and_equivalents | 3,531,000,000 United States dollar | superseded | [clm_F0BC38106BAF](/claim/clm_F0BC38106BAF.md) - 2022-05-18 to 2022-08-26 | shares_outstanding | 282,077,025 shares | superseded | [clm_74F0E5BFFA19](/claim/clm_74F0E5BFFA19.md) - 2022-07-31 to 2023-07-31 | revenue | 12,726,000,000 United States dollar | superseded | [clm_448FD51A223E](/claim/clm_448FD51A223E.md) - 2022-07-31 to 2022-10-31 | cash_and_equivalents | 2,796,000,000 United States dollar | superseded | [clm_67C2A61A1EF5](/claim/clm_67C2A61A1EF5.md) - 2022-07-31 to 2023-07-31 | operating_income | 2,571,000,000 United States dollar | superseded | [clm_7E65D3B8F7A5](/claim/clm_7E65D3B8F7A5.md) - 2022-07-31 to 2022-10-31 | total_assets | 27,734,000,000 United States dollar | superseded | [clm_A1A66950A80E](/claim/clm_A1A66950A80E.md) - 2022-07-31 to 2022-10-31 | total_equity | 16,441,000,000 United States dollar | superseded | [clm_B0C7D275F4C8](/claim/clm_B0C7D275F4C8.md) - 2022-07-31 to 2023-07-31 | net_income | 2,066,000,000 United States dollar | superseded | [clm_EA74E549058F](/claim/clm_EA74E549058F.md) - 2022-07-31 to 2023-07-31 | research_and_development | 2,347,000,000 United States dollar | superseded | [clm_F93B63E39C22](/claim/clm_F93B63E39C22.md) - 2022-08-26 to 2022-11-21 | shares_outstanding | 281,869,879 shares | superseded | [clm_AE4E8E3DE2DD](/claim/clm_AE4E8E3DE2DD.md) - 2022-10-31 to 2023-01-31 | cash_and_equivalents | 2,125,000,000 United States dollar | superseded | [clm_3BC07402C220](/claim/clm_3BC07402C220.md) - 2022-10-31 to 2023-01-31 | quarterly_net_income | 40,000,000 United States dollar | superseded | [clm_43086BA382C1](/claim/clm_43086BA382C1.md) - 2022-10-31 to 2023-01-31 | quarterly_operating_income | 76,000,000 United States dollar | superseded | [clm_45EA80834F26](/claim/clm_45EA80834F26.md) - 2022-10-31 to 2023-01-31 | total_equity | 16,067,000,000 United States dollar | superseded | [clm_842483C6ED49](/claim/clm_842483C6ED49.md) - 2022-10-31 to 2023-01-31 | quarterly_research_and_development | 625,000,000 United States dollar | superseded | [clm_F2FC233F90F3](/claim/clm_F2FC233F90F3.md) - 2022-10-31 to 2023-01-31 | quarterly_revenue | 2,597,000,000 United States dollar | superseded | [clm_FC44F108CFC6](/claim/clm_FC44F108CFC6.md) - 2022-10-31 to 2023-01-31 | total_assets | 27,085,000,000 United States dollar | superseded | [clm_FE5522944B61](/claim/clm_FE5522944B61.md) - 2022-11-21 to 2023-02-16 | shares_outstanding | 280,925,350 shares | superseded | [clm_74DA412BF980](/claim/clm_74DA412BF980.md) ## 2023 - 2023-01-31 to 2023-04-30 | quarterly_revenue | 3,041,000,000 United States dollar | superseded | [clm_2B1D5A58D758](/claim/clm_2B1D5A58D758.md) - 2023-01-31 to 2023-04-30 | total_assets | 27,202,000,000 United States dollar | superseded | [clm_54C19C4C2B41](/claim/clm_54C19C4C2B41.md) - 2023-01-31 to 2023-04-30 | quarterly_research_and_development | 630,000,000 United States dollar | superseded | [clm_619416102468](/claim/clm_619416102468.md) - 2023-01-31 to 2023-04-30 | cash_and_equivalents | 1,547,000,000 United States dollar | superseded | [clm_72539BB759D9](/claim/clm_72539BB759D9.md) - 2023-01-31 to 2023-04-30 | total_equity | 15,842,000,000 United States dollar | superseded | [clm_88721691A097](/claim/clm_88721691A097.md) - 2023-01-31 to 2023-04-30 | quarterly_net_income | 168,000,000 United States dollar | superseded | [clm_CC6ED54DB590](/claim/clm_CC6ED54DB590.md) - 2023-02-16 to 2023-05-16 | shares_outstanding | 280,546,394 shares | superseded | [clm_4F408269A0ED](/claim/clm_4F408269A0ED.md) - 2023-04-30 to 2023-10-31 | quarterly_revenue | 6,018,000,000 United States dollar | superseded | [clm_59DD4F3E448E](/claim/clm_59DD4F3E448E.md) - 2023-04-30 to 2023-10-31 | quarterly_operating_income | 2,778,000,000 United States dollar | superseded | [clm_7511C39886AE](/claim/clm_7511C39886AE.md) - 2023-04-30 to 2023-07-31 | total_equity | 17,592,000,000 United States dollar | superseded | [clm_9FAAC102655E](/claim/clm_9FAAC102655E.md) - 2023-04-30 to 2023-10-31 | quarterly_research_and_development | 604,000,000 United States dollar | superseded | [clm_AC19087EA768](/claim/clm_AC19087EA768.md) - 2023-04-30 to 2023-07-31 | total_assets | 28,921,000,000 United States dollar | superseded | [clm_C64D64D17B62](/claim/clm_C64D64D17B62.md) - 2023-04-30 to 2023-07-31 | cash_and_equivalents | 3,745,000,000 United States dollar | superseded | [clm_D50A39316E3E](/claim/clm_D50A39316E3E.md) - 2023-04-30 to 2023-10-31 | quarterly_net_income | 2,087,000,000 United States dollar | superseded | [clm_FE8EAE8EA898](/claim/clm_FE8EAE8EA898.md) - 2023-05-04 | board_member | Ryan Roslansky | valid | [clm_BF04602A33DD](/claim/clm_BF04602A33DD.md) - 2023-05-04 | board_member | Eric S. Yuan | valid | [clm_DDB4E7F444CA](/claim/clm_DDB4E7F444CA.md) - 2023-05-16 to 2023-08-25 | shares_outstanding | 280,059,722 shares | superseded | [clm_DBE769F69C01](/claim/clm_DBE769F69C01.md) - 2023-07-31 to 2023-10-31 | cash_and_equivalents | 2,848,000,000 United States dollar | superseded | [clm_14393F2A2042](/claim/clm_14393F2A2042.md) - 2023-07-31 to 2024-07-31 | research_and_development | 2,539,000,000 United States dollar | superseded | [clm_34CBAFC5C2A9](/claim/clm_34CBAFC5C2A9.md) - 2023-07-31 to 2024-07-31 | net_income | 2,384,000,000 United States dollar | superseded | [clm_3DDB9FEDBE5B](/claim/clm_3DDB9FEDBE5B.md) - 2023-07-31 to 2024-07-31 | operating_income | 3,141,000,000 United States dollar | superseded | [clm_80D838A42166](/claim/clm_80D838A42166.md) - 2023-07-31 to 2024-07-31 | revenue | 14,368,000,000 United States dollar | superseded | [clm_A5E5BD86785D](/claim/clm_A5E5BD86785D.md) - 2023-07-31 to 2023-10-31 | total_assets | 27,780,000,000 United States dollar | superseded | [clm_AA436AC008A8](/claim/clm_AA436AC008A8.md) - 2023-07-31 to 2023-10-31 | total_equity | 17,269,000,000 United States dollar | superseded | [clm_E7491F8C1856](/claim/clm_E7491F8C1856.md) - 2023-08-01 | cfo | Sandeep Aujla | valid | [clm_77C1293C3A75](/claim/clm_77C1293C3A75.md) - 2023-08-25 to 2023-11-20 | shares_outstanding | 280,259,493 shares | superseded | [clm_28A5C9A4C7B5](/claim/clm_28A5C9A4C7B5.md) - 2023-10-31 to 2024-01-31 | cash_and_equivalents | 1,734,000,000 United States dollar | superseded | [clm_0BAB9FEB8213](/claim/clm_0BAB9FEB8213.md) - 2023-10-31 to 2024-01-31 | quarterly_revenue | 2,978,000,000 United States dollar | superseded | [clm_19391E748BED](/claim/clm_19391E748BED.md) - 2023-10-31 to 2024-01-31 | quarterly_operating_income | 307,000,000 United States dollar | superseded | [clm_2096A465922F](/claim/clm_2096A465922F.md) - 2023-10-31 to 2024-01-31 | total_equity | 16,992,000,000 United States dollar | superseded | [clm_88328C75B14B](/claim/clm_88328C75B14B.md) - 2023-10-31 to 2024-01-31 | total_assets | 28,488,000,000 United States dollar | superseded | [clm_8D2BA19073C2](/claim/clm_8D2BA19073C2.md) - 2023-10-31 to 2024-01-31 | quarterly_net_income | 241,000,000 United States dollar | superseded | [clm_9E2BE0795CF3](/claim/clm_9E2BE0795CF3.md) - 2023-10-31 to 2024-01-31 | quarterly_research_and_development | 680,000,000 United States dollar | superseded | [clm_FB2AE4AF1517](/claim/clm_FB2AE4AF1517.md) - 2023-11-20 to 2024-02-15 | shares_outstanding | 279,936,000 shares | superseded | [clm_22AF966ABC56](/claim/clm_22AF966ABC56.md) ## 2024 - 2024-01-31 to 2024-04-30 | quarterly_operating_income | 369,000,000 United States dollar | superseded | [clm_075A16CA00C8](/claim/clm_075A16CA00C8.md) - 2024-01-31 to 2024-04-30 | total_assets | 29,688,000,000 United States dollar | superseded | [clm_3DCAF6AAC904](/claim/clm_3DCAF6AAC904.md) - 2024-01-31 to 2024-04-30 | cash_and_equivalents | 1,474,000,000 United States dollar | superseded | [clm_598D14262546](/claim/clm_598D14262546.md) - 2024-01-31 to 2024-04-30 | quarterly_net_income | 353,000,000 United States dollar | superseded | [clm_866B3D63E107](/claim/clm_866B3D63E107.md) - 2024-01-31 to 2024-04-30 | quarterly_research_and_development | 678,000,000 United States dollar | superseded | [clm_A2C5AA896349](/claim/clm_A2C5AA896349.md) - 2024-01-31 to 2024-04-30 | quarterly_revenue | 3,386,000,000 United States dollar | superseded | [clm_A44067E88170](/claim/clm_A44067E88170.md) - 2024-01-31 to 2024-04-30 | total_equity | 16,908,000,000 United States dollar | superseded | [clm_B59758333462](/claim/clm_B59758333462.md) - 2024-02-15 to 2024-05-16 | shares_outstanding | 279,979,000 shares | superseded | [clm_25A4A4EB21AF](/claim/clm_25A4A4EB21AF.md) - 2024-04-30 to 2024-10-31 | quarterly_operating_income | 3,105,000,000 United States dollar | superseded | [clm_5B4D1E5BB5BA](/claim/clm_5B4D1E5BB5BA.md) - 2024-04-30 to 2024-07-31 | cash_and_equivalents | 4,215,000,000 United States dollar | superseded | [clm_67E714E65B34](/claim/clm_67E714E65B34.md) - 2024-04-30 to 2024-07-31 | total_equity | 18,757,000,000 United States dollar | superseded | [clm_7780DAFCEED0](/claim/clm_7780DAFCEED0.md) - 2024-04-30 to 2024-10-31 | quarterly_research_and_development | 671,000,000 United States dollar | superseded | [clm_90A062886B4A](/claim/clm_90A062886B4A.md) - 2024-04-30 to 2024-10-31 | quarterly_revenue | 6,737,000,000 United States dollar | superseded | [clm_A1870FFDB107](/claim/clm_A1870FFDB107.md) - 2024-04-30 to 2024-07-31 | total_assets | 31,560,000,000 United States dollar | superseded | [clm_A39BDCCA1C76](/claim/clm_A39BDCCA1C76.md) - 2024-04-30 to 2024-10-31 | quarterly_net_income | 2,389,000,000 United States dollar | superseded | [clm_EAAD20EA9086](/claim/clm_EAAD20EA9086.md) - 2024-05-02 | board_member | Vasant Prabhu | valid | [clm_5E4C9C81E13E](/claim/clm_5E4C9C81E13E.md) - 2024-05-16 to 2024-08-27 | shares_outstanding | 279,547,000 shares | superseded | [clm_886057721CA2](/claim/clm_886057721CA2.md) - 2024-07-24 | board_member | Forrest Norrod | valid | [clm_3B6A632E97BF](/claim/clm_3B6A632E97BF.md) - 2024-07-31 to 2025-07-31 | operating_income | 3,630,000,000 United States dollar | superseded | [clm_68C1DF13599F](/claim/clm_68C1DF13599F.md) - 2024-07-31 to 2025-07-31 | research_and_development | 2,754,000,000 United States dollar | superseded | [clm_7928FE181BC8](/claim/clm_7928FE181BC8.md) - 2024-07-31 to 2025-07-31 | revenue | 16,285,000,000 United States dollar | superseded | [clm_84D22C65692E](/claim/clm_84D22C65692E.md) - 2024-07-31 to 2024-10-31 | total_equity | 18,436,000,000 United States dollar | superseded | [clm_9BAD2CCC3DED](/claim/clm_9BAD2CCC3DED.md) - 2024-07-31 to 2025-07-31 | net_income | 2,963,000,000 United States dollar | superseded | [clm_AF28556EDDEB](/claim/clm_AF28556EDDEB.md) - 2024-07-31 to 2024-10-31 | cash_and_equivalents | 3,609,000,000 United States dollar | superseded | [clm_D3993F2DB44F](/claim/clm_D3993F2DB44F.md) - 2024-07-31 to 2024-10-31 | total_assets | 32,132,000,000 United States dollar | superseded | [clm_F5179E714C9F](/claim/clm_F5179E714C9F.md) - 2024-08-27 to 2024-11-14 | shares_outstanding | 280,292,000 shares | superseded | [clm_8FF09608867F](/claim/clm_8FF09608867F.md) - 2024-10-31 to 2025-01-31 | total_equity | 18,136,000,000 United States dollar | superseded | [clm_32F80721604B](/claim/clm_32F80721604B.md) - 2024-10-31 to 2025-01-31 | quarterly_revenue | 3,283,000,000 United States dollar | superseded | [clm_3B850AD8640B](/claim/clm_3B850AD8640B.md) - 2024-10-31 to 2025-01-31 | cash_and_equivalents | 2,872,000,000 United States dollar | superseded | [clm_4B476D18C374](/claim/clm_4B476D18C374.md) - 2024-10-31 to 2025-01-31 | total_assets | 33,193,000,000 United States dollar | superseded | [clm_A9CAEE6B0020](/claim/clm_A9CAEE6B0020.md) - 2024-10-31 to 2025-01-31 | quarterly_net_income | 197,000,000 United States dollar | superseded | [clm_B19E4E2EE14C](/claim/clm_B19E4E2EE14C.md) - 2024-10-31 to 2025-01-31 | quarterly_operating_income | 271,000,000 United States dollar | superseded | [clm_B3F53D4F07AF](/claim/clm_B3F53D4F07AF.md) - 2024-10-31 to 2025-01-31 | quarterly_research_and_development | 704,000,000 United States dollar | superseded | [clm_DECBC7261118](/claim/clm_DECBC7261118.md) - 2024-11-14 to 2025-02-19 | shares_outstanding | 280,035,000 shares | superseded | [clm_E0CE9A551606](/claim/clm_E0CE9A551606.md) ## 2025 - 2025-01-31 to 2025-04-30 | total_assets | 31,682,000,000 United States dollar | superseded | [clm_691BE1029906](/claim/clm_691BE1029906.md) - 2025-01-31 to 2025-04-30 | total_equity | 17,949,000,000 United States dollar | superseded | [clm_6D6A091B6B64](/claim/clm_6D6A091B6B64.md) - 2025-01-31 to 2025-04-30 | quarterly_operating_income | 593,000,000 United States dollar | superseded | [clm_82F0517B7357](/claim/clm_82F0517B7357.md) - 2025-01-31 to 2025-04-30 | cash_and_equivalents | 2,435,000,000 United States dollar | superseded | [clm_BE48005AE86C](/claim/clm_BE48005AE86C.md) - 2025-01-31 to 2025-04-30 | quarterly_revenue | 3,963,000,000 United States dollar | superseded | [clm_BEB272593A5A](/claim/clm_BEB272593A5A.md) - 2025-01-31 to 2025-04-30 | quarterly_net_income | 471,000,000 United States dollar | superseded | [clm_C46D0450FF93](/claim/clm_C46D0450FF93.md) - 2025-01-31 to 2025-04-30 | quarterly_research_and_development | 716,000,000 United States dollar | superseded | [clm_CAC179DB6F1B](/claim/clm_CAC179DB6F1B.md) - 2025-02-19 to 2025-05-15 | shares_outstanding | 279,562,000 shares | superseded | [clm_53EB67C73749](/claim/clm_53EB67C73749.md) - 2025-04-30 to 2025-10-31 | quarterly_operating_income | 3,720,000,000 United States dollar | superseded | [clm_0FC200F683A2](/claim/clm_0FC200F683A2.md) - 2025-04-30 to 2025-07-31 | total_assets | 36,593,000,000 United States dollar | superseded | [clm_1306D2D0B6E1](/claim/clm_1306D2D0B6E1.md) - 2025-04-30 to 2025-07-31 | cash_and_equivalents | 5,443,000,000 United States dollar | superseded | [clm_68BFC689ABB6](/claim/clm_68BFC689ABB6.md) - 2025-04-30 to 2025-10-31 | quarterly_revenue | 7,754,000,000 United States dollar | superseded | [clm_6C087A34D589](/claim/clm_6C087A34D589.md) - 2025-04-30 to 2025-07-31 | total_equity | 20,125,000,000 United States dollar | superseded | [clm_6DDB0AEDA821](/claim/clm_6DDB0AEDA821.md) - 2025-04-30 to 2025-10-31 | quarterly_net_income | 2,820,000,000 United States dollar | superseded | [clm_9F3A37B00540](/claim/clm_9F3A37B00540.md) - 2025-04-30 to 2025-10-31 | quarterly_research_and_development | 707,000,000 United States dollar | superseded | [clm_C92EC8936C80](/claim/clm_C92EC8936C80.md) - 2025-05-15 to 2025-08-26 | shares_outstanding | 278,947,000 shares | superseded | [clm_1D474FD67D69](/claim/clm_1D474FD67D69.md) - 2025-07-31 to 2026-07-31 | revenue | 18,831,000,000 United States dollar | superseded | [clm_04BFE802F5B6](/claim/clm_04BFE802F5B6.md) - 2025-07-31 to 2025-10-31 | cash_and_equivalents | 2,884,000,000 United States dollar | superseded | [clm_09F3511E40D1](/claim/clm_09F3511E40D1.md) - 2025-07-31 to 2026-07-31 | research_and_development | 2,928,000,000 United States dollar | superseded | [clm_66D9B303E053](/claim/clm_66D9B303E053.md) - 2025-07-31 to 2026-07-31 | operating_income | 4,923,000,000 United States dollar | superseded | [clm_952CA1FE37F4](/claim/clm_952CA1FE37F4.md) - 2025-07-31 to 2025-10-31 | total_assets | 36,958,000,000 United States dollar | superseded | [clm_A8B4E46855B8](/claim/clm_A8B4E46855B8.md) - 2025-07-31 to 2025-10-31 | total_equity | 19,710,000,000 United States dollar | superseded | [clm_ABB67187E279](/claim/clm_ABB67187E279.md) - 2025-07-31 to 2026-07-31 | net_income | 3,869,000,000 United States dollar | superseded | [clm_C1021D747F68](/claim/clm_C1021D747F68.md) - 2025-08-26 to 2025-11-13 | shares_outstanding | 278,805,000 shares | superseded | [clm_216C09F54B2D](/claim/clm_216C09F54B2D.md) - 2025-10-31 to 2026-01-31 | quarterly_operating_income | 534,000,000 United States dollar | superseded | [clm_88546840A26C](/claim/clm_88546840A26C.md) - 2025-10-31 to 2026-01-31 | cash_and_equivalents | 3,506,000,000 United States dollar | superseded | [clm_9F41B9C71D40](/claim/clm_9F41B9C71D40.md) - 2025-10-31 to 2026-01-31 | quarterly_research_and_development | 843,000,000 United States dollar | superseded | [clm_A218E8F6BA51](/claim/clm_A218E8F6BA51.md) - 2025-10-31 to 2026-01-31 | total_equity | 19,322,000,000 United States dollar | superseded | [clm_B033FB6902A2](/claim/clm_B033FB6902A2.md) - 2025-10-31 to 2026-01-31 | quarterly_net_income | 446,000,000 United States dollar | superseded | [clm_D9C1F760B105](/claim/clm_D9C1F760B105.md) - 2025-10-31 to 2026-01-31 | total_assets | 33,191,000,000 United States dollar | superseded | [clm_E5D324669BF7](/claim/clm_E5D324669BF7.md) - 2025-10-31 to 2026-01-31 | quarterly_revenue | 3,885,000,000 United States dollar | superseded | [clm_E8ABE315700C](/claim/clm_E8ABE315700C.md) - 2025-11-13 to 2026-02-20 | shares_outstanding | 278,400,000 shares | superseded | [clm_970E78622A39](/claim/clm_970E78622A39.md) ## 2026 - 2026-01-31 to 2026-04-30 | quarterly_net_income | 693,000,000 United States dollar | superseded | [clm_143397295843](/claim/clm_143397295843.md) - 2026-01-31 to 2026-04-30 | cash_and_equivalents | 2,942,000,000 United States dollar | superseded | [clm_3317596255A3](/claim/clm_3317596255A3.md) - 2026-01-31 to 2026-04-30 | quarterly_operating_income | 855,000,000 United States dollar | superseded | [clm_4018AFF14EB8](/claim/clm_4018AFF14EB8.md) - 2026-01-31 to 2026-04-30 | total_equity | 19,055,000,000 United States dollar | superseded | [clm_6C8C00381DCE](/claim/clm_6C8C00381DCE.md) - 2026-01-31 to 2026-04-30 | quarterly_research_and_development | 836,000,000 United States dollar | superseded | [clm_8984213E033D](/claim/clm_8984213E033D.md) - 2026-01-31 to 2026-04-30 | total_assets | 34,282,000,000 United States dollar | superseded | [clm_8BBEDF039A6C](/claim/clm_8BBEDF039A6C.md) - 2026-01-31 to 2026-04-30 | quarterly_revenue | 4,651,000,000 United States dollar | superseded | [clm_DEA7078D8A5D](/claim/clm_DEA7078D8A5D.md) - 2026-02-20 to 2026-05-14 | shares_outstanding | 276,550,000 shares | superseded | [clm_32DB0A945C77](/claim/clm_32DB0A945C77.md) - 2026-04-30 | quarterly_revenue | 8,558,000,000 United States dollar | valid | [clm_0CDC1B21F955](/claim/clm_0CDC1B21F955.md) - 2026-04-30 to 2026-07-31 | total_equity | 20,629,000,000 United States dollar | superseded | [clm_0D96323D022E](/claim/clm_0D96323D022E.md) - 2026-04-30 to 2026-07-31 | total_assets | 39,330,000,000 United States dollar | superseded | [clm_81573DB75D88](/claim/clm_81573DB75D88.md) - 2026-04-30 | quarterly_operating_income | 4,020,000,000 United States dollar | valid | [clm_DD7E0F82EB76](/claim/clm_DD7E0F82EB76.md) - 2026-04-30 | quarterly_research_and_development | 840,000,000 United States dollar | valid | [clm_EE99E8558E7E](/claim/clm_EE99E8558E7E.md) - 2026-04-30 | quarterly_net_income | 3,064,000,000 United States dollar | valid | [clm_EF44DCDC8A32](/claim/clm_EF44DCDC8A32.md) - 2026-04-30 to 2026-07-31 | cash_and_equivalents | 4,681,000,000 United States dollar | superseded | [clm_F2040245B8B1](/claim/clm_F2040245B8B1.md) - 2026-05-14 to 2026-08-31 | shares_outstanding | 273,537,000 shares | superseded | [clm_9CDE9D348B1F](/claim/clm_9CDE9D348B1F.md) - 2026-05-20 | restructuring | Plan to simplify structure, cut about 17% workforce, consider site closures | valid | [clm_18940D16840E](/claim/clm_18940D16840E.md) - 2026-07-31 | cash_and_equivalents | 4,705,000,000 United States dollar | valid | [clm_3A2CD74AA389](/claim/clm_3A2CD74AA389.md) - 2026-07-31 | net_income | 4,566,000,000 United States dollar | valid | [clm_4825434EF596](/claim/clm_4825434EF596.md) - 2026-07-31 | total_equity | 18,992,000,000 United States dollar | valid | [clm_7EE0A8F92475](/claim/clm_7EE0A8F92475.md) - 2026-07-31 | operating_income | 5,884,000,000 United States dollar | valid | [clm_94331C7D69F2](/claim/clm_94331C7D69F2.md) - 2026-07-31 | total_assets | 36,786,000,000 United States dollar | valid | [clm_BF0D49DE1644](/claim/clm_BF0D49DE1644.md) - 2026-07-31 | research_and_development | 3,376,000,000 United States dollar | valid | [clm_CFDBA79C79E0](/claim/clm_CFDBA79C79E0.md) - 2026-07-31 | revenue | 21,448,000,000 United States dollar | valid | [clm_D42E207FB9BD](/claim/clm_D42E207FB9BD.md) - 2026-08-01 | board_member | Adena Friedman | valid | [clm_83581C53476A](/claim/clm_83581C53476A.md) - 2026-08-01 | board_member | Bill McDermott | valid | [clm_C80BDD361BEB](/claim/clm_C80BDD361BEB.md) - 2026-08-31 | shares_outstanding | 267,236,000 shares | valid | [clm_F8A59882843E](/claim/clm_F8A59882843E.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.